Forest Laboratories Inc. et al v. Lupin Pharmaceuticals Inc. et al
Merz Pharma GmbH & Co. KGaA and Forest Laboratories Holdings Ltd. |
Sun India Pharmaceutical Industries Limited, Amneal Pharmaceuticals, LLC, Genpharm LP, Teva Pharmaceuticals USA Inc., Mylan Pharmaceuticals Inc., Apotex Inc., PLIVA d.d., Genpharm Inc., Cobalt Laboratories Inc., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Limited, Barr Laboratories Inc. and Interpharm Holdings Inc. |
Barr Pharmaceuticals Inc., Wockhardt USA LLC, Upsher-Smith Laboratories Inc., Interpharm Inc., Orchid Chemicals & Pharmaceuticals Ltd., Lupin Ltd., Forest Laboratories Inc., Apotex Corp., Alzheimer's Drug Discovery Foundation, Orgenus Pharma Inc., Institute For The Study of Aging, Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH and Lupin Pharmaceuticals Inc. |
Amneal Pharmaceuticals of New York LLC, Wockhardt Limited and Dr. Reddy's Laboratories Inc. |
1:2008cv00021 |
January 10, 2008 |
US District Court for the District of Delaware |
Wilmington Office |
XX US, Outside State |
Leonard P Stark |
Patent |
35 U.S.C. § 271 |
Defendant |
Docket Report
This docket was last retrieved on October 23, 2012. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 509 ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Matt Neiderman : D.I. #470 and 483 (rbe) |
Filing 508 ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of David Ellis Moore : see attached for list of D.I. # (dzb, ) |
Filing 507 ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Kelly E. Farnan : D.I. #401 (rbe) |
Filing 506 ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Morris, Nichols : D.I. # 100,101,102,152,153,165,240,241,273,284,403,468,476,477 (rwc) |
Filing 505 ORDER directing the return of sealed documents to the parties. Parties may claim sealed documents by sending an email, listing the item numbers, name, and firm address, to returnsealeddocs@ded.uscourts.gov. Parties not registered in CM/ECF may call 302-573-6170 to claim documents. Documents to be claimed by 10/16/12. Clerk shall contact parties when documents are ready for pick-up. (Docket attached with sealed items highlighted). Signed by Judge Leonard P. Stark on 10/1/12. (Attachments: #1 Annotated docket)(dzb, ) |
CORRECTING ENTRY: D.I. 505 deleted as it was docketed in the incorrect case. (dzb, ) |
Filing 504 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding advising Court that all actions have been dismissed and the cases can be closed. (Blumenfeld, Jack) |
Filing 503 ORAL ORDER: IT IS ORDERED that counsel are to provide the Court with a joint status report on or before November 9, 2010. ORDERED by Judge Leonard P. Stark on 11/2/10. Associated Cases: 1:08-cv-00021-LPS, 1:08-cv-00052-LPS(ntl) |
CASE CLOSED (ntl) |
Filing 502 SO ORDERED, re #466 Stipulation of Dismissal filed by Merz Pharma GmbH & Co. KGaA, Lupin Ltd., Lupin Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 9/27/2010. (rpg) |
Filing 501 NOTICE of CHANGE OF LAW FIRM AFFILIATION (G. Flattmann and M. Rupert now affiliated with Paul Hastings; Plaintiffs will be presented by Morris, Nichols; Paul Hastings and Jones Day) by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH (Noreika, Maryellen) |
Case reassigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (all documents should be filed in the lead case only, 1:08-cv-00021-LPS.) Associated Cases: 1:08-cv-00021-LPS, 1:08-cv-00052-LPS(rjb) |
Filing 500 SO ORDERED, re #498 Stipulation of Dismissal filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Mylan Pharmaceuticals Inc. Signed by Chief Judge Gregory M. Sleet on 9/1/2010. (asw) |
Filing 499 Letter to The Honorable Gregory M. Sleet from Maryellen Noreika regarding stipulations of dismissal for Mylan and Lupin - re #466 Stipulation of Dismissal, #498 Stipulation of Dismissal. (Noreika, Maryellen) |
Filing 498 STIPULATION of Dismissal as to Mylan Pharmaceuticals Inc. by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH, Mylan Pharmaceuticals Inc.. (Noreika, Maryellen) |
Filing 497 SO ORDERED re #496 Stipulation filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Mylan Pharmaceuticals Inc. This action is STAYED with respect to Mylan and all currently scheduled dates in this action with respect to Mylan are adjourned. Signed by Chief Judge Gregory M. Sleet on 7/27/10. (mmm) |
Filing 496 STIPULATION AND ORDER (staying litigation as to Mylan Pharmaceuticals Inc.) by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH, Mylan Pharmaceuticals Inc.. (Attachments: #1 Letter to The Honorable Gregory M. Sleet enclosing stipulation)(Noreika, Maryellen) |
CORRECTING ENTRY: docket item # 496 removed and docket item #495 PDF replaced with corrected document per counsel's telephone request on 7/13/2010 to Clerk of Court. (rpg) |
Filing 495 Letter to Judge Sleet from Matt Neiderman regarding Status Update - re #494 Letter. (Neiderman, Matt) (rpg). |
Filing 494 Letter to Judge Gregory M. Sleet from Matt Neiderman regarding status update - re #493 Letter. (Quinton, G.) |
Filing 493 Letter to The Honorable Gregory M. Sleet from Matt Neiderman regarding follow-up to Mylan Pharmaceuticals, Inc.'s letter of June 1, 2010. (Neiderman, Matt) |
Filing 492 NOTICE of WITHDRAWAL OF COUNSEL - appearance of James W. Parrett, Jr. as counsel for plaintiffs is hereby withdrawn - by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH (Noreika, Maryellen) |
Filing 491 Letter to The Honorable Gregory M. Sleet from Matt Neideman, Esq. regarding follow-up to Mylan Pharmaceutical, Inc.'s May 17, 2010 letter. (Neiderman, Matt) |
Filing 490 Letter to The Honorable Gregory M. Sleet from Matt Neiderman, Esq. regarding follow-up to Mylan Pharmaceuticals May 3, 2010 letter. (Neiderman, Matt) |
Filing 489 Letter to The Honorable Gregory M. Sleet from Matt Neiderman, Esq. regarding follow-up to Mylan Pharmaceuticals April 19, 2010 letter. (Neiderman, Matt) |
Filing 488 Letter to The Honorable Gregory M. Sleet from Matt Neiderman, Esq. regarding follow-up to Mylan Pharmaceuticals April 12, 2010 letter. (Neiderman, Matt) |
Filing 487 Letter to The Honorable Gregory M. Sleet from Matt Neiderman, Esq. regarding Follow-up to Mylan Pharmaceuticals April 5, 2010 letter. (Neiderman, Matt) |
Filing 486 Letter to The Honorable Gregory M. Sleet from Matt Neiderman, Esq. regarding follow-up to Defendant, Mylan Pharmaceuticals March 29, 2010 letter. (Neiderman, Matt) |
Filing 485 Letter to The Honorable Gregory M. Sleet from Matt Neiderman regarding follow-up to Defendant Mylan Pharmaceuticals March 22, 2010 letter. (Neiderman, Matt) |
Filing 484 REDACTED VERSION of #483 Exhibit to a Document (Exhibit B to Mylan Pharmaceuticals Inc.'s Reply to Plaintiffs Opposition to Mylans Motion to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto) by Mylan Pharmaceuticals Inc.. (Neiderman, Matt) |
Filing 483 SEALED EXHIBIT re #482 Reply Brief re Motion to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto (Exhibit B) by Mylan Pharmaceuticals Inc.. (Neiderman, Matt) |
CORRECTING ENTRY: Exhibit B re #482 REPLY BRIEF re #469 MOTION to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto filed by Mylan Pharmaceuticals Inc has been deleted per counsel's request that the document be sealed. Counsel shall refile Exhibit B underseal. (rpg) |
Filing 482 REPLY BRIEF re #469 MOTION to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto filed by Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, # 2 Exhibit B, #3 Exhibit C)(Neiderman, Matt) |
Filing 481 Letter to The Honorable Gregory M. Sleet from Matt Neiderman, Esq. regarding follow-up to Defendant, Mylan Pharmaceuticals March 16, 2010 letter. (Neiderman, Matt) |
Filing 480 NOTICE OF SUBSTITUTION OF COUNSEL re Mylan Pharmaceuticals Inc.: Entry of appearance of attorney Matt Neiderman. Attorney Daniel V. Folt, Esq. terminated. (Neiderman, Matt) |
Filing 479 Letter to The Honorable Gregory M. Sleet from Daniel V. Folt, Esq. regarding the Conference with Court staff on March 15, 2010 and the March 15, 2010 letter e-filed - re #478 Letter. (Folt, Daniel) |
Filing 478 Letter to The Honorable Gregory M. Sleet from Maryellen Noreika regarding cancellation of Pretrial Conference scheduled for March 16, 2010. (Noreika, Maryellen) |
Filing 477 SEALED DECLARATION re #476 Answering Brief in Opposition, DECLARATION OF ANDRES SAWICKI IN SUPPORT OF PLAINTIFF'S OPPOSITION TO MYLAN'S MOTION TO STRIKE THE SUPPLEMENTAL EXPERT REPORT OF ROBERTO MALINOW, M.D., PH.D. by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A-I)(Blumenfeld, Jack) |
Filing 476 SEALED ANSWERING BRIEF in Opposition re #469 MOTION to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto filed by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.Reply Brief due date per Local Rules is 3/25/2010. (Blumenfeld, Jack) |
ORAL ORDER SCHEDULING PRETRIAL CONFERENCE: A Pretrial Conference before the Honorable Gregory M. Sleet has been scheduled for Tuesday, March 16, 2010, at 10:00 AM. All counsel should report to Courtroom 4A. The current trial date(s) will also be discussed. Signed by Chief Judge Gregory M. Sleet on 3/10/2010. (ctd) |
Filing 475 NOTICE OF SERVICE of Mylan's Notice Pursuant to 35 U.S.C. 282 by Mylan Pharmaceuticals Inc..(Folt, Daniel) |
Filing 474 REDACTED VERSION of #468 Proposed Pretrial Order by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH, Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibits 1-12)(Blumenfeld, Jack) |
Filing 473 ORDER Cancelling Pretrial Conference on 2:00 PM 3/8/2010 before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 3/4/2010. (rpg) |
Filing 472 REDACTED VERSION of #470 Exhibit to a Document (Exhibit A to Motion to Strike Expert Report of Roberto Malinow and All Testimony Related Thereto) by Mylan Pharmaceuticals Inc.. (Folt, Daniel) |
Filing 471 EXHIBIT re #469 MOTION to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto (Exhibits B & C) by Mylan Pharmaceuticals Inc.. (Folt, Daniel) |
Filing 470 SEALED EXHIBIT re #469 MOTION to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto (Exhibit A) by Mylan Pharmaceuticals Inc.. (Folt, Daniel) |
Filing 469 MOTION to Strike Supplemental Expert Report of Roberto Malinow and All Testimony Relating Thereto - filed by Mylan Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)Motions referred to Leonard P. Stark.(Folt, Daniel) |
Filing 468 Proposed Pretrial Order SEALED by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH, Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibits 1 through 12)(Blumenfeld, Jack) |
Filing 467 NOTICE OF SERVICE of Supplemental Expert Report of Roberto Malinow, M.D., Ph.D. by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
SO ORDERED, re #465 Stipulation to Amend Protective Order filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 2/16/2010. (rpg) |
Filing 466 STIPULATION of Dismissal by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Lupin Ltd., Lupin Pharmaceuticals Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
Filing 465 STIPULATION to Amend Protective Order re #275 Stipulation,,, by Mylan Pharmaceuticals Inc.. (Folt, Daniel) |
Filing 464 SO ORDERED, re #458 Stipulation, filed by Merz Pharma GmbH & Co. KGaA, Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Chief Judge Gregory M. Sleet on 12/28/2009. (asw) |
Filing 463 NOTICE OF SERVICE of 1) Opposition Expert Report of Roberto Malinow, M.D., Ph.D.; 2) Expert Report of John P. Murry, Jr., Ph.D.; 3) Opposition Expert Report of Rachelle S. Doody, M.D., Ph.D.; 4) Opposition Expert Report of Martin R. Farlow, M.D.; and 5) Opposition Expert Report of Christopher A. Lipinski, Ph.D. by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA.(Noreika, Maryellen) |
Filing 462 NOTICE OF SERVICE of Rebuttal Report and Exhibits of John Onley, M.D. by Mylan Pharmaceuticals Inc..(Folt, Daniel) |
CORRECTING ENTRY: D.I. 461, Notice of Service was filed in error and has been deleted from the docket. (asw) |
Filing 460 NOTICE OF SERVICE of 1) Opposition Expert Report of Roberto Malinow, M.D., Ph.D.; 2) Expert Report of John P. Murray, Jr., Ph.D.; 3) Opposition Expert Report of Rachelle S. Doody, M.D., Ph.D.; and 4) Opposition Expert Report of Martin R. Farlow, M.D. by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
SO ORDERED, re #459 Stipulation to Stay Litigation as to Lupin Defendants by Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co., KGaA, Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 12/16/2009. (rpg) |
Filing 459 STIPULATION to Stay Litigation as to Lupin Defendants by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Lupin Ltd., Lupin Pharmaceuticals Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Letter to Judge Stark)(Noreika, Maryellen) |
Filing 458 Proposed STIPULATION and Order by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 457 NOTICE OF SUBSTITUTION OF COUNSEL re Mylan Pharmaceuticals Inc.: Entry of appearance of attorney Daniel V. Folt. Attorney Richard L. Horwitz, Esq. and David E. Moore, Esq. terminated. (Folt, Daniel) |
Filing 456 NOTICE OF SERVICE of Expert Report of Harry C. Boghigian, Expert Report of Paul Spencer Fishman, M.D., Ph.D., Expert Report by David A. Greenberg, M.D., Ph.D., Expert Report of Jerry Joseph Buccafusco, Ph.D., and Expert Report of Cameron K. Weiffenbach by Mylan Pharmaceuticals Inc..(Moore, David) |
Filing 455 NOTICE OF SERVICE of Expert Report of Dr. Rachelle S. Doody Regarding Mylan by Forest Laboratories Holdings Ltd., Forest Laboratories Inc..(Noreika, Maryellen) |
Filing 454 NOTICE OF SERVICE of Expert Report of Dr. Rachelle S. Doody Regarding Lupin by Forest Laboratories Holdings Ltd., Forest Laboratories Inc..(Noreika, Maryellen) |
SO ORDERED, re #453 Stipulation to Stay this Action with Respect to "DRL", filed by Merz Pharma GmbH & Co. KGaA, Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 11/17/2009. (rpg) |
Filing 453 STIPULATION AND ORDER - staying action with respect to DRL by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Letter to Judge Stark encl. stipulation and order)(Noreika, Maryellen) |
Filing 452 SO ORDERED, re #450 Stipulation of Dismissal filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Teva Pharmaceuticals USA Inc. Signed by Chief Judge Gregory M. Sleet on 11/10/2009. (asw) |
Filing 451 Letter to Clerks of Court from Gerald J. Flattman, Jr., regarding Documents filed with the Judicial Panel on Multidistrict Litigation. (Attachments: #1 Revised Schedule of Actions, #2 Proof of Service, #3 Revised Proof of Service)(rpg) |
Filing 450 STIPULATION of Dismissal (as to Teva Pharmaceuticals USA, Inc.) by Teva Pharmaceuticals USA Inc., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 449 NOTICE OF SERVICE of Teva USA's Supplemental Responses and Objections to Plaintiffs' First Set of Collective Interrogatories by Teva Pharmaceuticals USA Inc..(Moore, David) |
Filing 448 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Supplemental Responses and Objections to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-4) by Mylan Pharmaceuticals Inc..(Moore, David) |
Filing 447 Letter dated 10/28/09 to Clerk USDC/DE from Gerald Flattmann, Jr. regarding MDL motion for transfer and consolidation. (ntl) |
Filing 446 NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants' First Set of Interrogatories Directed to Common Discovery Issues (Nos. 1-4, 9, 12) As They Pertain to Defendant by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 445 NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants' First Set of Interrogatories Directed to Common Discovery Issues (Nos. 1-4, 9, 12) As They Pertain to Defendant DRL by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 444 NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants' First Set of Interrogatories Directed to Common Discovery Issues (Nos. 1-4, 9, 12) As They Pertain to Defendant Mylan by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 443 NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants' First Set of Interrogatories Directed to Common Discovery Issues (Nos. 1-4, 9, 12) As They Pertain to Defendant Teva by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 442 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Supplemental Responses to Plaintiffs' First Set of Collective Interrogatories (Nos. 1-7) by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Moore, David) |
Filing 441 ACKNOWLEDGMENT OF RECEIPT by USDC/NJ of Supplemental Record, #440 Letter re sealed documents. (ntl) |
Filing 440 Letter to Clerk USDC/NJ from Clerk USDC/DE regarding Sealed documents re Supplemental transfer record. (ntl) |
EXIT (Supplemental) RECORD to District of New Jersey re transfer of the causes of action of defendants Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma, Inc. -- the following SEALED documents (from C.A. No. 08-21-GMS-LPS) were mailed: D.I. Nos. 46, 89-90, 100-102, 133-135, 152-153, 162-163, 165, 188, 227 and 284. Associated Cases: 1:08-cv-00021-GMS-LPS, 1:08-cv-00291-GMS-LPS(ntl) |
Filing 439 SO ORDERED, re #437 Stipulation filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Cobalt Laboratories Inc. Signed by Chief Judge Gregory M. Sleet on 10/20/09. (mmm) |
Filing 438 ORDER Cancelling Status Telephone Conference set for 10/20/2009 at 10:00 AM before Judge Leonard P. Stark. ( Issues Moot ). Signed by Judge Leonard P. Stark on 10/20/2009. (rpg) |
Filing 437 STIPULATION AND ORDER (of dismissal with regard to Cobalt Laboratories Inc.) by Cobalt Laboratories Inc., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 436 NOTICE OF SERVICE of (i) Plaintiffs' Objections and Responses to Defendants' Second Set of Collective Interrogatories and (ii) Plaintiffs' Objections and Responses to Defendants' First Set of Collective Requests for Admission by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 435 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Second Supplemental Initial Disclosures by Mylan Pharmaceuticals Inc..(Moore, David) |
Filing 434 SO ORDERED, re #433 Stipulation, filed by Merz Pharma GmbH & Co. KGaA, Sun India Pharmaceutical Industries Limited, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Chief Judge Gregory M. Sleet on 10/15/09. (mmm) |
SO ORDERED, re #432 Stipulation filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Genpharm LP, Merz Pharmaceuticals GmbH, Genpharm Inc. Ordered by Chief Judge Gregory M. Sleet on 10/14/2009. (asw) |
Filing 433 STIPULATION regarding resolution of action between Plaintiffs and Sun by Forest Laboratories Inc., Sun India Pharmaceutical Industries Limited, Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 432 STIPULATION AND ORDER OF DISMISSAL OF THE GENPHARM DEFENDANTS by Forest Laboratories Inc., Genpharm Inc., Genpharm LP, Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 431 ORDER Denying Letter Requests to Allow Letters Requesting Motions for Summary Judgment. Signed by Judge Leonard P. Stark on 10/7/2009. (rpg) |
Filing 430 Letter to The Honorable Gregory M. Sleet from Jack B. Blumenfeld regarding response to Dr. Reddy's October 5, 2009 letter - re #429 Letter. (Blumenfeld, Jack) |
Filing 429 Letter to The Honorable Gregory M. Sleet from Richard L. Horwitz regarding Dr. Reddy's request for summary judgment letter briefing. (Horwitz, Richard) |
EXIT RECORD (partial) to District of New Jersey: pursuant to Chief Judge Sleet's Memorandum and Order #407 , the following docket items were sent to USDC/NJ regarding the transfer of the causes of action as to defendants Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma, Inc. -- D.I. Nos. #1 , #7 , #43 , #44 , #45 , #51 , #53 , #58 , #64 , #76 , #83 , #87 , #88 , #92 , #96 , #97 , #99 , #107 , #108 , #109 , #142 , #143 , #144 , #146 , #155 , #156 , #168 , #169 , #179 , #186 , #191 , #196 , #226 , #228 , #238 , #264 , #270 , #277 , #407 , #420 and the docket sheet. In C.A. No. 08-291 the following docket items were sent: D.I. Nos. #1 , #7 , #10 and the docket sheet. Associated Cases: 1:08-cv-00021-GMS-LPS, 1:08-cv-00291-GMS-LPS(ntl) |
SO ORDERED, re #428 STIPULATION TO EXTEND TIME by which Plaintiffs shall respond to Defendants' First Set of Collective Requests for Admission and Defendants' Second Set of Collective Interrogatories to October 16, 2009 filed by Merz Pharma GmbH & Co. KGaA, Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Cobalt Laboratories Inc., Mylan Pharmaceuticals Inc., Lupin Ltd., Lupin Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Genpharm LP, Teva Pharmaceuticals USA Inc., Genpharm Inc.. Signed by Judge Leonard P. Stark on 10/2/2009. (rpg) |
Filing 428 STIPULATION TO EXTEND TIME by which Plaintiffs shall respond to Defendants' First Set of Collective Requests for Admission and Defendants' Second Set of Collective Interrogatories to October 16, 2009 - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Teva Pharmaceuticals USA Inc., Forest Laboratories Inc., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 427 NOTICE OF SERVICE of 1) Forest's Objections to Defendants' Second Notice of Deposition of Forest Pursuant to Fed. R. Civ. P. 30(b)(6) and 2) Merz's Objections to Defendants' Second Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
SO ORDERED, re #425 STIPULATION TO EXTEND TIME - STIPULATION AND ORDER REGARDING PROPOSED MODIFICATIONS TO THE SCHEDULING ORDER. ( Fact Discovery now due by 10/30/2009, Close of Expert Testimony now due by 1/22/2010, Opening In-Limine Briefs now due by 2/5/2010, Answering In-Limine Briefs now due by 2/19/2010, Reply In-Limine Briefs now due by 2/26/2010, Proposed Pretrail Order now due by 2/26/2010, and Final Pretrial Conference reset for 3/8/2010 at 2:00 PM in Chambers 6C - Parties shall report to Courtroom 6C ). Trial Date remains 4/5/2010. Signed by Judge Leonard P. Stark on 9/22/2009. (rpg) |
Filing 426 MEMORANDUM AND ORDER ADOPTING IN PART AND OVERRULING IN PART #373 REPORT AND RECOMMENDATIONS re #369 MOTION for Pro Hac Vice Appearance of Attorney Gabriel Brier, Michael P. Hogan and Daniel C. Wiesner filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceutic. Signed by Chief Judge Gregory M. Sleet on 9/21/2009. (asw) |
Filing 425 STIPULATION TO EXTEND TIME - STIPULATION AND ORDER REGARDING PROPOSED MODIFICATIONS TO THE SCHEDULING ORDER to See Exhibit A - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Teva Pharmaceuticals USA Inc., Forest Laboratories Inc., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A)(Blumenfeld, Jack) |
SO ORDERED, re #420 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to no later than five (5) business days after Plaintiffs' causes of action against Orchid India and Orgenus are docketed in the United States District Court for the Dist STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to no later than five (5) business days after Plaintiffs' causes of action against Orchid India and Orgenus are docketed in the United States District Court for the Dist filed by Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc. Signed by Judge Leonard P. Stark on 9/14/2009. (rpg) |
Filing 424 NOTICE to Take Deposition of Robert Sanzen on a date to be determined by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 423 NOTICE to Take Deposition of Jason Harper on September 30, 2009 by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Louden, Karen) |
Filing 422 ANSWER to #406 Answer to Complaint, Counterclaim,, PLAINTIFFS' ANSWER TO DEFENDANTS LUPIN PHARMACEUTICALS, INC.'S AND LUPIN LTD.'S COUNTERCLAIMS by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 421 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Supplemental Initial Disclosures by Mylan Pharmaceuticals Inc..(Moore, David) |
Filing 420 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to no later than five (5) business days after Plaintiffs' causes of action against Orchid India and Orgenus are docketed in the United States District Court for the District of New Jersey - filed by Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc.. (Moore, David) |
Filing 419 SO ORDERED, re #415 Stipulation of Dismissal, filed by Merz Pharma GmbH & Co. KGaA, Wockhardt USA LLC, Wockhardt Limited, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Chief Judge Gregory M. Sleet on 9/11/2009. (asw) |
Filing 418 SO ORDERED, re #409 Stipulation of Dismissal, filed by Merz Pharma GmbH & Co. KGaA, Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York LLC, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Chief Judge Gregory M. Sleet on 9/11/2009. (asw) |
Filing 417 SO ORDERED, re #413 Stipulation of Dismissal filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Apotex Inc., Apotex Corp. Signed by Chief Judge Gregory M. Sleet on 9/11/2009. (asw) |
Filing 416 SO ORDERED, re #412 Stipulation filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Upsher-Smith Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Chief Judge Gregory M. Sleet on 9/11/2009. (asw) |
Filing 415 STIPULATION of Dismissal (as to Wockhardt USA, LLC (formerly known as Wockhardt USA Inc.) and Wockhardt Limited) by Wockhardt USA LLC, Wockhardt Limited, Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 414 NOTICE OF SERVICE of Dr. W. Wolfgang Fleischhacker's Responses and Objections to Dr. Reddy's and Amneal's Subpoena Duces Tecum by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 413 STIPULATION of Dismissal (as to Apotex Inc. and Apotex Corp.) by Forest Laboratories Inc., Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 412 Joint STIPULATION and Order by Upsher-Smith Laboratories Inc., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 411 NOTICE OF SERVICE of Defendants' Second Set of Collective Interrogatories and Defendants' First Set of Collective Requests For Admission, Filed on Behalf of All Defendants by Teva Pharmaceuticals USA Inc..(Moore, David) |
Filing 410 NOTICE OF SERVICE of Apotex, inc.'s First Set of Interrogatories by Apotex Inc..(Moore, David) |
Filing 409 STIPULATION of Dismissal as to AMNEAL PHARMACEUTICALS OF NEW YORK LLC AND AMNEAL PHARMACEUTICALS, LLC by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 408 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Moore, David) |
Filing 407 MEMORANDUM AND ORDER GRANTING #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, OVERRULING #270 Objections, filed by Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc., ADOPTING #264 REPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holding, DENYING AS MOOT #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Chemicals & Pharmaceuticals Ltd., DENYING AS MOOT #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Orgenus Pharma Inc., GRANTING #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Chief Judge Gregory M. Sleet on 8/27/2009. (asw) |
Filing 406 Amended ANSWER to Complaint, COUNTERCLAIM Answer and Counterclaims of Defendants Lupin Pharmaceuticals, Inc. and Lupin, LTD against all parties by Lupin Pharmaceuticals Inc., Lupin Ltd.. (Attachments: #1 certificate of service)(Brauerman, Stephen) |
Filing 405 RESPONSE TO OBJECTIONS by Forest Laboratories Inc., Forest Laboratories Holdings Ltd. re SO ORDERED, Set Deadlines/Hearings,,. (Blumenfeld, Jack) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 8/20/2009. (Court Reporter K. Maurer.) (ntl) |
Filing 404 NOTICE OF SERVICE of Wockhardt USA, LLC's and Wockhardt Limited's Objections to Plaintiffs' Notice of Deposition by Wockhardt USA LLC, Wockhardt Limited.(Farnan, Kelly) |
Filing 403 SEALED Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding telephone conference scheduled for August 20, 2009. (Attachments: #1 Exhibit A & B)(Blumenfeld, Jack) |
Filing 402 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Apotex's request for an exception to the July 8, 2009 Scheduling Order. (Blumenfeld, Jack) |
Filing 401 SEALED Letter to The Hon. Leonard P. Stark from Kelly E. Farnan regarding preparation for parties' teleconference with Court on August 20, 2009 - re #195 SO ORDERED,,,. (Farnan, Kelly) |
Filing 400 Letter to The Honorable Leanoard P. Stark from David E. Moore, Esquire regarding discovery dispute -- location of deposition - re #393 Order Setting Teleconference. (Moore, David) |
SO ORDERED, re #399 MOTION to Amend/Correct Defendants' UNOPPOSED Motion for Leave to Amend Answers filed by Lupin Ltd., Lupin Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 8/14/2009. (rpg) |
Filing 399 MOTION to Amend/Correct Defendants' UNOPPOSED Motion for Leave to Amend Answers - filed by Lupin Pharmaceuticals Inc., Lupin Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit 1, #3 Exhibit 2, #4 Text of Proposed Order, #5 Certificate of Service)Motions referred to Leonard P. Stark.(Brauerman, Stephen) |
Filing 398 NOTICE to Take Deposition of Merz Pharma GmbH & Co. KGaA and Merz Pharmaceuticals GmbH (second notice) on a date within a reasonable time after the parties have finished production of documents (filed on behalf of all defendants) by Teva Pharmaceuticals USA Inc..(Moore, David) |
Filing 397 NOTICE to Take Deposition of Forest Laboratories, Inc. and Forest Laboratories, Holdings, Ltd. (second notice) on a date after the parties have finished production of documents (filed on behalf of all defendants) by Teva Pharmaceuticals USA Inc..(Moore, David) |
Filing 396 NOTICE OF SERVICE of Notice of Service for The Lupin Defendants' Objections and Responses to Plaintiffs' Notice of Disposition Pursuant to Rule 30(b)(6) re #306 Notice to Take Deposition, by Lupin Pharmaceuticals Inc., Lupin Ltd.. Related document: #306 Notice to Take Deposition, filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH.(Brauerman, Stephen) |
Filing 395 NOTICE OF SERVICE of Defendant Upsher-Smith Laboratories, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Rule 30(b)(6) re #311 Notice to Take Deposition by Upsher-Smith Laboratories Inc.. Related document: #311 Notice to Take Deposition filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH.(Gaza, Anne) |
Filing 394 NOTICE to Take Deposition of Ellen Gettenberg on September 11, 2009 at 9:30 a.m. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 393 Order Setting Teleconference: Discovery Telephone Conference set for 8/20/2009 11:00 AM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 8/7/2009. (rpg) |
Filing 392 NOTICE of Issuance of Subpoena Duces Tecum on Dr. W. Wolfgang Fleischhacker, c/o Alexander L. Greenberg, Esquire (on behalf of all defendants) by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited (Moore, David) |
SO ORDERED, re #388 STIPULATION TO EXTEND TIME for Plaintiffs' to respond to Defendants' Objections to the Report and Recommendations Regarding Claim Construction (and stipulating that plaintiffs can file a consolidated response of no more than twenty pages). Plaintiffs' response to Defendants' Objections to the Report and Recommendations Regarding Claim Construction due by 8/20/2009. Signed by Judge Leonard P. Stark on 7/28/2009. (rpg) |
Filing 391 NOTICE OF SERVICE of Plaintiffs' First Supplemental Rule 26(a)(1) Initial Disclosures by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 390 NOTICE to Take Deposition of W. Wolfgang Fleischhacker, M.D. on September 9, 2009 by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 389 Letter to The Honorable Gregory M. Sleet from Richard D. Kirk, Esquire regarding Enclosing Materials Relating to Objections to Report and Recommendation Regarding Claim Construction (D.I. 373). (Kirk, Richard) |
Filing 388 STIPULATION TO EXTEND TIME for Plaintiffs' to respond to Defendants' Objections to the Report and Recommendations Regarding Claim Construction (and stipulating that plaintiffs can file a consolidated response of no more than twenty pages) to August 20, 2009 - filed by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA LLC, Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 387 NOTICE OF SERVICE of re #376 Notice (Other) by Institute For The Study of Aging. Related document: #376 Notice (Other) filed by Wockhardt USA LLC, Wockhardt Limited.(Parker, Titania) |
Filing 386 NOTICE OF SERVICE of re #375 Notice (Other) by Alzheimer's Drug Discovery Foundation. Related document: #375 Notice (Other) filed by Wockhardt USA LLC, Wockhardt Limited.(Parker, Titania) |
SO ORDERED, re #385 MOTION for Pro Hac Vice Appearance of Attorney Thomas J. Meloro, Eugene L. Chang and Colman B. Ragan of Willkie Farr & Gallagher LLP filed by Teva Pharmaceuticals USA Inc. Signed by Judge Leonard P. Stark on 7/22/2009. (rpg) |
CORRECTING ENTRY: The Lupin Defendants' Objections to Magistrate Judge's Report and Recommendation Regarding Claim Construction (D.I. 383) has been deleted and replaced with the correct version. (fms) |
Filing 385 MOTION for Pro Hac Vice Appearance of Attorney Thomas J. Meloro, Eugene L. Chang and Colman B. Ragan of Willkie Farr & Gallagher LLP - filed by Teva Pharmaceuticals USA Inc.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 384 OBJECTIONS by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Upsher-Smith Laboratories Inc., Orgenus Pharma Inc., Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc., Apotex Inc., Apotex Corp. to #373 REPORT AND RECOMMENDATIONS (Gaza, Anne) Modified on 7/21/2009 (dzs, ). |
Filing 383 OBJECTION to #373 Report and Recommendations Regarding Claim Construction by Lupin Ltd.. (Attachments: #1 Certificate of Service)(Kirk, Richard) (Additional attachment(s) added on 7/22/2009: #2 Objections) (fms). |
Filing 382 OBJECTIONS by Cobalt Laboratories Inc., Teva Pharmaceuticals USA Inc., Wockhardt USA LLC, Wockhardt Limited, Sun India Pharmaceutical Industries Limited to D.I. 373 Report and Recommendation Regarding Claim Construction. (Matterer, Mary) |
Filing 381 OBJECTION to #373 Report and Recommendations Regarding Claim Construction by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited. (Moore, David) |
Filing 380 ORDER - Amending Scheduling Order Deadlines: Discovery due by 10/2/2009; Opening Expert Reports due 10/23/09; Rebuttal Expert Reports due 11/20/09; Expert Discovery completed by 12/23/09. Signed by Judge Leonard P. Stark on 7/20/09. (rwc) |
Filing 379 NOTICE OF SERVICE of Genpharm's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Rule 30(b)(6) by Genpharm Inc., Genpharm LP.(Moore, David) |
Filing 378 NOTICE OF SERVICE of Mylan's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Rule 30(b)(6) by Mylan Pharmaceuticals Inc..(Moore, David) |
Filing 377 Letter to The Honorable Leonard P. Stark from David E. Moore regarding case status. (Moore, David) |
Filing 376 NOTICE of Service of Subpoena to The Institute for the Study of Aging by Wockhardt USA LLC, Wockhardt Limited (Attachments: #1 Exhibit 1)(Farnan, Kelly) |
Filing 375 NOTICE of Service of Subpoena to The Alzheimer's Drug Discovery Foundation by Wockhardt USA LLC, Wockhardt Limited (Attachments: #1 Exhibit 1)(Farnan, Kelly) |
Filing 374 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding non-compliance with May 7, 2009 Order - re #321 Order Cancelling Deadline, Set Scheduling Order Deadlines,,,,. (Attachments: #1 Exhibit A)(Blumenfeld, Jack) |
Filing 373 REPORT AND RECOMMENDATIONS REGARDING CLAIM CONSTRUCTION. Signed by Judge Leonard P. Stark on 7/2/2009. (rpg) |
SO ORDERED, re #358 MOTION for Pro Hac Vice Appearance of Attorney Nicole W. Stafford of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 6/29/2009. (rpg) |
SO ORDERED, re #346 STIPULATION TO EXTEND TIME for Cobalt to respond to Plaintiffs' Requests for Admission to June 15, 2009 filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Cobalt Laboratories Inc. Signed by Judge Leonard P. Stark on 6/25/2009. (rpg) |
Filing 372 NOTICE OF SERVICE of Orchid Chemicals & Pharmaceuticals Ltd.'s and Orgenus Pharma Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) by Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Moore, David) |
SO ORDERED, re #369 MOTION for Pro Hac Vice Appearance of Attorney Gabriel Brier, Michael P. Hogan and Daniel C. Wiesner filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 6/19/2009. (rpg) |
Filing 371 NOTICE OF SERVICE of Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Rule 30(b)(6) by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 370 OBJECTIONS by Cobalt Laboratories Inc. to #303 Notice to Take Deposition Pursuant to Rule 30(b)(6). (Matterer, Mary) |
Filing 369 MOTION for Pro Hac Vice Appearance of Attorney Gabriel Brier, Michael P. Hogan and Daniel C. Wiesner - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Motions referred to Leonard P. Stark.(Noreika, Maryellen) |
Filing 368 NOTICE OF SERVICE of Apotex, Inc.'s and Apotex Corp.'s Objections to Plaintiffs' Notice of Deposition by Apotex Inc., Apotex Corp..(Muttamara-Walker, Doungamon) |
Filing 367 NOTICE OF SERVICE of Responses of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. to Plaintiffs' First Set of Requests For Admission (Nos. 1-28) by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Moore, David) |
Filing 366 NOTICE OF SERVICE of Responses of Amneal Pharmaceuticals of New York, LLC and Amneal Pharmaceuticals LLC to Plaintiffs' First Set of Requests For Admission (Nos. 1-28) by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC.(Moore, David) |
Filing 365 NOTICE OF SERVICE of Defendant Wockhardt's Response to Plaintiffs' Requests for Admissions by Wockhardt USA LLC, Wockhardt Limited.(Farnan, Kelly) |
Filing 364 NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Responses to Plaintiffs' Request for Admission by Sun India Pharmaceutical Industries Limited.(Seaman, John) |
Filing 363 NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.'s Responses to Plaintiffs' Requests For Admission by Teva Pharmaceuticals USA Inc..(Moore, David) |
Filing 362 NOTICE OF SERVICE of Orchid Pharmaceuticals Inc.'s, Orchid Chemicals & Pharmaceuticals Ltd.'s and Orgenus Pharma Inc.'s Responses and Objections to Plaintiffs' Requests for Admission to Orchid by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Moore, David) |
Filing 361 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Responses to Plaintiffs' Notice of Deposition of Teva Pharmaceuticals USA, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) by Teva Pharmaceuticals USA Inc..(Moore, David) |
Filing 358 MOTION for Pro Hac Vice Appearance of Attorney Nicole W. Stafford of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 360 NOTICE of Service of Objections and Responses to Third Party Subpoena Duces Tecum filed by Steven E. Lipman Counsel for Adda C. Gogoris, Esq., and S. Peter Ludwig, Esq. (rpg) Modified on 6/9/2009 (rpg). |
Filing 359 NOTICE of Service of Objections and Responses to Third Party Subpoena Duces Tecum filed by Steven E. Lipman Counsel for Adda C. Gogoris, Esq., and S. Peter Ludwig, Esq. (rpg) Modified on 6/9/2009 (rpg). |
Remark: docket updated to indicate that Wockhardt USA, Inc. is now Wockhardt USA, LLC re #356 . (rpg) |
Filing 357 Disclosure Statement pursuant to Rule 7.1 filed by Wockhardt USA Inc., Wockhardt Limited. (Farnan, Kelly) |
Filing 356 NOTICE of Conversion of Wockhardt USA, Inc. to Wockhardt USA, LLC by Wockhardt USA Inc., Wockhardt Limited (Farnan, Kelly) |
SO ORDERED, re #350 STIPULATION TO EXTEND TIME to respond to Plaintiffs' Requests for Admission to June 15, 2009 filed by Orchid Chemicals & Pharmaceuticals Ltd., Orchid Pharmaceuticals Inc., Orgenus Pharma Inc. Signed by Judge Leonard P. Stark on 6/2/2009. (rpg) |
SO ORDERED, re #353 STIPULATION TO EXTEND TIME to respond to Plaintiffs' Requests for Admission to June 15, 2009 filed by Teva Pharmaceuticals USA Inc. Signed by Judge Leonard P. Stark on 6/2/2009. (rpg) |
SO ORDERED, re #355 STIPULATION TO EXTEND TIME time within which Defendants Wockhardt USA, Inc. and Wockhardt Limited shall respond to Plaintiffs' Requests for Admission to June 15, 2009 filed by Wockhardt Limited, Wockhardt USA Inc. Signed by Judge Leonard P. Stark on 6/2/2009. (rpg) |
Filing 355 STIPULATION TO EXTEND TIME time within which Defendants Wockhardt USA, Inc. and Wockhardt Limited shall respond to Plaintiffs' Requests for Admission to June 15, 2009 - filed by Wockhardt USA Inc., Wockhardt Limited. (Farnan, Kelly) |
Filing 354 NOTICE OF SERVICE of Defendant Lupin Pharmaceuticals, Inc. and Lupin Ltd's Responses and Objections to Plaintiffs' Requests for Admission to Lupin re #317 Notice of Service, by Lupin Pharmaceuticals Inc., Lupin Ltd.. Related document: #317 Notice of Service, filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH.(Kirk, Richard) |
Filing 353 STIPULATION TO EXTEND TIME to respond to Plaintiffs' Requests for Admission to June 15, 2009 - filed by Teva Pharmaceuticals USA Inc.. (Muttamara-Walker, Doungamon) |
Filing 352 NOTICE OF SERVICE of Mylan's Responses to Plaintiffs' First Set of Requests For Admission (Nos. 1-28) and Genpharm ULC and Genpharm, L.P.'s Responses to Plaintiffs' First Set of Requests For Admission (Nos. 1-28) by Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc..(Moore, David) |
Filing 351 NOTICE OF SERVICE of Apotex's Response to Plaintiffs' Requests For Admission by Apotex Inc., Apotex Corp..(Moore, David) |
Filing 350 STIPULATION TO EXTEND TIME to respond to Plaintiffs' Requests for Admission to June 15, 2009 - filed by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc.. (Moore, David) |
Filing 349 NOTICE OF SERVICE of Answer to Plaintiff's Requests for Admission by Cobalt Laboratories Inc..(Matterer, Mary) |
SO ORDERED, re #344 MOTION for Pro Hac Vice Appearance of Attorney Evangeline Shih filed by Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 6/1/2009. (rpg) |
SO ORDERED, re #347 STIPULATION TO EXTEND TIME Response to Plaintiffs' Requests for Admission to June 15, 2009 filed by Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York LLC. Signed by Judge Leonard P. Stark on 6/1/2009. (rpg) |
SO ORDERED, re #348 STIPULATION TO EXTEND TIME Defendants' (Dr. Reddy Lab Inc. & Dr. Reddy Lab Ltd) Response to Plaintiffs' Requests for Admission to June 15, 2009 STIPULATION TO EXTEND TIME Defendants' (Dr. Reddy Lab Inc. & Dr. Reddy Lab Ltd) Response to Plaintiffs' Requests for Admission to June 15, 2009 filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited. Signed by Judge Leonard P. Stark on 6/1/2009. (rpg) |
CORRECTING ENTRY re D.I. 348: Dr. Reddy's Labs Inc. and Dr. Reddy's Labs Ltd. were added as the proper filing party; defendant Amneal was removed. (ntl) |
Filing 348 STIPULATION TO EXTEND TIME Defendants' (Dr. Reddy Lab Inc. & Dr. Reddy Lab Ltd) Response to Plaintiffs' Requests for Admission to June 15, 2009 - filed by Dr. Reddy's Lab Inc. & Dr. Reddy's Lab Ltd. (Moore, David) Modified on 5/29/2009 (ntl). |
Filing 347 STIPULATION TO EXTEND TIME Response to Plaintiffs' Requests for Admission to June 15, 2009 - filed by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC. (Moore, David) |
Filing 346 STIPULATION TO EXTEND TIME for Cobalt to respond to Plaintiffs' Requests for Admission to June 15, 2009 - filed by Cobalt Laboratories Inc., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Matterer, Mary) |
SO ORDERED, re #345 Stipulation To Extend Time for Sun India Pharmaceutical Industries Limited to respond to Plaintiffs Requests for Admission to June 15, 2009 (including). All other dates in the Scheduling Order (D.I. 114), as amended on May 7, 2009 #321 , remain unchanged. Signed by Judge Leonard P. Stark on 5/28/2009. (rpg) |
Filing 345 STIPULATION Extending Time to Respond to Discovery by Sun India Pharmaceutical Industries Limited. (Seaman, John) |
Filing 344 MOTION for Pro Hac Vice Appearance of Attorney Evangeline Shih - filed by Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Motions referred to Leonard P. Stark.(Noreika, Maryellen) |
Filing 343 NOTICE OF SERVICE of Defendant Upsher-Smith Laboratories, Inc.'s Response to Plaintiffs' Requests for Admission by Upsher-Smith Laboratories Inc..(Gaza, Anne) |
Filing 342 ANSWER to #335 Amended Answer to Complaint, Counterclaim of Wockhardt USA Inc. and Wockhardt Limited by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 341 ANSWER to #322 Amended Answer to Complaint, Counterclaim of Mylan Pharmeceuticals Inc. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 340 ANSWER to #323 Amended Answer to Complaint, Counterclaim of Genpharm ULC and Genpharm, L.P. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 339 ANSWER to #325 Amended Answer to Complaint,, Counterclaim, of Apotex Inc. and Apotex Corp. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 338 ANSWER to #330 Answer to Complaint, Counterclaim of Cobalt Laboratories Inc. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 337 ANSWER to #327 Amended Answer to Complaint, Counterclaim of Amneal Pharmaceuticals of New York, LLC and Amneal Pharmaceuticals, LLC by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 336 ANSWER to #328 Amended Answer to Complaint, Counterclaim of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 335 AMENDED ANSWER to #49 Answer to Complaint, Counterclaim, #1 Complaint,,, COUNTERCLAIM against all plaintiffs by Wockhardt USA Inc., Wockhardt Limited. (Farnan, Kelly) |
Filing 334 NOTICE OF SERVICE of G. Patrick Sage's Resposnes and Objections to Defendants' Subpoena by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 333 NOTICE of Issuance of Subpoena Duces Tecum upon S. Peter Ludwig c/o Steve Lipman by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited (Moore, David) |
Filing 332 SUBPOENA Returned Executed as to Adda C. Gogoris at Darby & Darby, P.C. (re: DI 314) on 5/1/09 (Moore, David) |
SO ORDERED, re #329 Stipulation of Dismissal filed by PLIVA-HRVATSKA d.o.o., Barr Pharmaceuticals Inc., PLIVA d.d., Barr Laboratories Inc. Ordered by Chief Judge Gregory M. Sleet on 5/11/2009. (asw) |
Filing 331 Amended ANSWER to #1 Complaint,, by Upsher-Smith Laboratories Inc..(Gaza, Anne) |
Filing 330 Amended ANSWER to #1 Complaint,, with Jury Demand, COUNTERCLAIM against Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 329 STIPULATION of Dismissal of the Barr Defendants Without Prejudice by Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o.. (Moore, David) |
Filing 328 AMENDED ANSWER to #1 Complaint,,, COUNTERCLAIM against all plaintiffs by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited. (Moore, David) |
Filing 327 AMENDED ANSWER to #1 Complaint,,, COUNTERCLAIM against all plaintiffs by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC. (Moore, David) |
Filing 326 AMENDED ANSWER to #1 Complaint,, by Teva Pharmaceuticals USA Inc.. (Moore, David) |
Filing 325 AMENDED ANSWER to #94 Answer to Complaint, Counterclaim, #1 Complaint,,, COUNTERCLAIM (SECOND AMENDED ANSWER, DEFENSES AND COUNTERCLAIMS) against Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH by Apotex Inc., Apotex Corp.. (Moore, David) |
Filing 324 AMENDED ANSWER to #1 Complaint,, by Orchid Pharmaceuticals Inc.. (Moore, David) |
Filing 323 AMENDED ANSWER to #1 Complaint,,, COUNTERCLAIM (SECOND AMENDED ANSWER AND COUNTERCLAIMS) against all plaintiffs by Genpharm Inc., Genpharm LP. (Moore, David) |
Filing 322 AMENDED ANSWER to #1 Complaint,,, COUNTERCLAIM (SECOND AMENDED ANSWER AND COUNTERCLAIMS) against all plaintiffs by Mylan Pharmaceuticals Inc.. (Moore, David) |
SO ORDERED MOTION for Leave to File DEFENDANTS' UNOPPOSED MOTION FOR LEAVE TO AMEND ANSWERS) - filed by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Cobalt Laboratories Inc., Orchid Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Mylan Pharmaceuticals Inc., Apotex Inc., Apotex Corp.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1 (Mylan Pharmaeuticals Inc.), # 3 Exhibit 2 (Genpharm ULC and Genpharm, L.P.), # 4 Exhibit 3 (Orchid Pharmaceuticals Inc.), # 5 Exhibit 4 (Apotex Inc. and Apotex Corp.), # 6 Exhibit 5 (Cobalt Laboratories Inc.), # 7 Exhibit 6 (Teva Pharmaceuticals USA, Inc.), # 8 Exhibit 7 (Amneal Pharmaceuticals of NY, LLC and Amneal Pharmaceuticals, LLC), # 9 Exhibit 8 (Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.), # 10 Exhibit 9 (Upsher-Smith Laboratories, Inc.), # 11 Exhibit 10 (Wockhardt USA Inc. and Wockhardt Limited), # 12 Exhibit 11 (Mylan redline), # 13 Exhibit 12 (Genpharm redline), # 14 Exhibit 13 (Orchid redline), # 15 Exhibit 14 (Apotex redline), # 16 Exhibit 15 (Cobalt redline), # 17 Exhibit 16 (Teva redline), # 18 Exhibit 17 (Amneal redline), # 19 Exhibit 18 (Dr. Reddy redline), # 20 Exhibit 19 (Upsher-Smith redline), # 21 Exhibit 20 (Wockhardt redline), # 22 Exhibit A),. Signed by Judge Leonard P. Stark on 5/7/2009. (rpg) |
Filing 321 ORDER Cancelling Telephone Conference set for 5/7/2009 at 12:00 PM before Judge Leonard P. Stark and Resetting Scheduling Order Deadlines ( Discovery due by 10/2/2009, Opening Summary Judgment Letters due by 10/9/2009, Answering Summary Judgment Letters due 10/14/2009, and Reply Summary Judgment Letters due 10/16/2009. Summary Judgment Status Telephone Conference set for 10/16/2009 is hereby RESCHEDULED for 10/20/2009 10:00 AM before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 5/7/2009. (rpg) |
Filing 320 MOTION for Leave to File DEFENDANTS' UNOPPOSED MOTION FOR LEAVE TO AMEND ANSWERS) - filed by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Cobalt Laboratories Inc., Orchid Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Mylan Pharmaceuticals Inc., Apotex Inc., Apotex Corp.. (Attachments: #1 Text of Proposed Order, #2 Exhibit 1 (Mylan Pharmaeuticals Inc.), #3 Exhibit 2 (Genpharm ULC and Genpharm, L.P.), #4 Exhibit 3 (Orchid Pharmaceuticals Inc.), #5 Exhibit 4 (Apotex Inc. and Apotex Corp.), #6 Exhibit 5 (Cobalt Laboratories Inc.), #7 Exhibit 6 (Teva Pharmaceuticals USA, Inc.), #8 Exhibit 7 (Amneal Pharmaceuticals of NY, LLC and Amneal Pharmaceuticals, LLC), #9 Exhibit 8 (Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.), #10 Exhibit 9 (Upsher-Smith Laboratories, Inc.), #11 Exhibit 10 (Wockhardt USA Inc. and Wockhardt Limited), #12 Exhibit 11 (Mylan redline), #13 Exhibit 12 (Genpharm redline), #14 Exhibit 13 (Orchid redline), #15 Exhibit 14 (Apotex redline), #16 Exhibit 15 (Cobalt redline), #17 Exhibit 16 (Teva redline), #18 Exhibit 17 (Amneal redline), #19 Exhibit 18 (Dr. Reddy redline), #20 Exhibit 19 (Upsher-Smith redline), #21 Exhibit 20 (Wockhardt redline), #22 Exhibit A)Motions referred to Leonard P. Stark.(Moore, David) |
Filing 319 SUBPOENA Returned Executed as to G. Patrick Sage, Esq. on April 30, 2009 (Attachments: #1 Exhibit A)(Ferguson, Stephen) |
Filing 318 Joint Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding submission in preparation for May 7, 2009 teleconference. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M)(Blumenfeld, Jack) |
Filing 317 NOTICE OF SERVICE of Requests for Admission to Amneal, Apotex, Barr, Cobalt, DRL, Genpharm, Lupin, Mylan, Orchid, Sun, Teva, USL, And Wockhardt by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 316 Order Setting Discovery Teleconference:Telephone Conference set for 5/7/2009 12:00 PM before Judge Leonard P. Stark; a joint letter to the Court due 5/5/09 by 12:00 pm. Signed by Judge Leonard P. Stark on 5/1/09. (ntl) |
Filing 315 NOTICE OF SERVICE of Forest's Objections to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) and Merz's Objections to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 314 NOTICE of Issuance of Subpoena Duces Tecum upon Adda C. Gogoris by Mylan Pharmaceuticals Inc. (Muttamara-Walker, Doungamon) |
Filing 313 NOTICE to Take Deposition of G. Patrick Sage on June 1, 2009 by Upsher-Smith Laboratories Inc.. (Attachments: #1 Exhibit 1 - Subpoena, #2 Exhibit A - Definitions)(Ferguson, Stephen) |
Filing 312 NOTICE to Take Deposition of Wockhardt USA Inc. and Wockhardt Limited on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 311 NOTICE to Take Deposition of Upsher-Smith Laboratories, Inc. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 310 NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 309 NOTICE to Take Deposition of Sun India Pharmaceutical Industries Limited (a/k/a Sun Pharmaceuticals Industries, Ltd.) on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 308 NOTICE to Take Deposition of Orchid Chemicals & Pharmaceuticals, Ltd. (d/b/a Orchid Healthcare) and Orgenus Pharma, Inc. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 307 NOTICE to Take Deposition of Mylan Pharmaceuticals, Inc. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 306 NOTICE to Take Deposition of Lupin Pharmaceuticals, USA, Inc. and Lupin, Ltd. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 305 NOTICE to Take Deposition of Genpharm ULC (as successor to Genpharm, Inc.) and Genpharm, L.P. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 304 NOTICE to Take Deposition of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories Limited on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 303 NOTICE to Take Deposition of Cobalt Laboratories, Inc. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 302 NOTICE to Take Deposition of Apotex, Inc. and Apotex Corp. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 301 NOTICE to Take Deposition of Amneal Pharmaceuticals of New York, LLC and Amneal Pharmaceuticals, LLC, successors in interest to Interpharm, Inc. and Interpharm Holdings, Inc. on a date to be agreed upon by the parties by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 300 NOTICE OF SERVICE of Notices of Deposition by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibits A through UU)(Noreika, Maryellen) |
SO ORDERED, re #298 Stipulation,,, filed by Merz Pharma GmbH & Co. KGaA, Amneal Pharmaceuticals, LLC, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Amneal Pharmaceuticals of New York LLC, Orchid Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Dr. Reddy's Laboratories Limited, Barr Pharmaceuticals Inc., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, PLIVA d.d., Orgenus Pharma Inc., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc. Signed by Judge Leonard P. Stark on 4/16/2009. (rpg) |
SO ORDERED GRANTING LETTER REQUEST re #286 Letter from Maryellen Noreika regarding proposed modification to the Court's April 7, 2009 order concerning discovery disputes. Signed by Judge Leonard P. Stark on 4/16/2009. (rpg) |
Filing 299 REDACTED VERSION of #284 Memorandum in Opposition, by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J - PART 1, #11 Exhibit J - PART 2, #12 Exhibit J - PART 3, #13 Exhibit K - PART 1, #14 Exhibit K - PART 2, #15 Exhibit K - PART 3, #16 Exhibit L - PART 1, #17 Exhibit L - PART 2, #18 Exhibit M, #19 Exhibit N)(Noreika, Maryellen) |
Filing 298 Joint STIPULATION Stipulated Order Establishing Protocol for Discovery of Electronic Information by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 297 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things (Nos. 66-68) by Genpharm Inc., Genpharm LP.(Horwitz, Richard) |
Filing 296 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things (Nos. 66-68) by Mylan Pharmaceuticals Inc..(Horwitz, Richard) |
Filing 295 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things (Nos. 66-68) by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC.(Horwitz, Richard) |
Filing 294 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things (Nos. 66-68) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Horwitz, Richard) |
Filing 293 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things (Nos. 66-68) by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Horwitz, Richard) |
Filing 292 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things (Nos. 66-68) by Apotex Inc., Apotex Corp..(Horwitz, Richard) |
Filing 291 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things by Teva Pharmaceuticals USA Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA-HRVATSKA d.o.o..(Horwitz, Richard) |
Filing 290 NOTICE OF SERVICE of Defendant Lupin Pharmaceuticals Inc. and Lupin Ltd.'s Reponses and Objection to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things to Defendants (Nos. 66-68) by Lupin Pharmaceuticals Inc., Lupin Ltd..(Brauerman, Stephen) |
Filing 289 NOTICE OF SERVICE of Defendant Sun India Pharmaceutical Industries Ltd to Plaintiff's Second Set of Collective requests for Production of Documents by Sun India Pharmaceutical Industries Limited.(Seaman, John) |
Filing 288 NOTICE OF SERVICE of Defendant Wockhardt's Objections and Responses to Plaintiff Forest's Second Set of Collective Requests for Production of Documents and Things (Nos. 66-68) by Wockhardt USA Inc., Wockhardt Limited.(Farnan, Kelly) |
Filing 287 NOTICE OF SERVICE of Response of Upsher-Smith Laboratories, Inc. to Plaintiffs' Second Set Of Collective Requests For The Production Of Documents And Things To Defendants (Nos. 66-68) re #265 Notice of Service, by Upsher-Smith Laboratories Inc.. Related document: #265 Notice of Service, filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH.(Gaza, Anne) |
Filing 286 Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding proposed modification to the Court's April 7, 2009 order concerning discovery disputes. (Attachments: #1 Text of Proposed Order)(Noreika, Maryellen) |
Filing 285 NOTICE OF SERVICE of Objections and Responses to Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things to Defendants (Nos. 66-68) by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 284 SEALED MEMORANDUM in Opposition Plaintiffs' Response to Defendants' Objections to Magistrate Judge Stark's Report and Recommendation to Grant Plaintiffs' Motions to Transfer filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.Reply Brief due date per Local Rules is 4/20/2009. (Attachments: #1 Exhibits A through N)(Parrett, James) |
Filing 283 ORDER re discovery issues discussed during 3/26/09 teleconference re #276 Transcript, #282 Letter, #273 Letter, #271 Letter. Signed by Judge Leonard P. Stark on 4/7/09. (ntl) |
Filing 282 Joint Letter to The Honorable Leonard P. Stark from James W. Parrett, Jr. and Richard L. Horwitz regarding current status of two discovery disputes. (Parrett, James) |
Filing 281 NOTICE to Take Deposition of Merz Pharma GMBH & CO.KGAA, and Merz Pharmaceuticals GMBH on TBD by Lupin Ltd.. (Attachments: #1 Certificate of Service)(Kirk, Richard) |
Filing 280 NOTICE to Take Deposition of Forest Laboratories, Inc. and Forest Laboratories Holdings LTD on TBD by Lupin Ltd.. (Attachments: #1 Certificate of Service)(Kirk, Richard) |
Filing 279 REDACTED VERSION of #273 Letter by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1 & 2)(Noreika, Maryellen) |
Filing 278 REDACTED VERSION of #271 Letter to The Honorable Leonard P. Stark from Richard L. Horwitz regarding discovery dispute by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp.. (Attachments: #1 Exhibit A-E)(Horwitz, Richard) |
Filing 277 Letter to The Honorable Gregory M. Sleet from David E. Moore regarding Objections to Report & Recommendations - re #264 REPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holding. (Moore, David) |
SO ORDERED, re #275 Stipulation,,, filed by Merz Pharma GmbH & Co. KGaA, Amneal Pharmaceuticals, LLC, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Amneal Pharmaceuticals of New York LLC, Orchid Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Dr. Reddy's Laboratories Limited, Barr Pharmaceuticals Inc., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Interpharm Inc., PLIVA d.d., Orgenus Pharma Inc., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc. Signed by Judge Leonard P. Stark on 3/30/2009. (rpg) |
SO ORDERED, re #272 MOTION for Pro Hac Vice Appearance of Attorney Ketan Pastakia of Willkie Farr & Gallagher LLP filed by PLIVA-HRVATSKA d.o.o., Barr Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., PLIVA d.d., Barr Laboratories Inc. Signed by Judge Leonard P. Stark on 3/30/2009. (rpg) |
Filing 276 Official Transcript of Telephone Conference held on Thursday, March 26, 2009 before Magistrate Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/17/2009. Redacted Transcript Deadline set for 4/27/2009. Release of Transcript Restriction set for 6/25/2009. (bpg) |
Filing 275 STIPULATION TO AMEND PROTECTIVE ORDER by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 3/26/2009. (Court Reporter B. Gaffigan.) (ntl) |
Filing 274 NOTICE OF SERVICE of Plaintiffs' Response to Cobalt Laboratories Inc.'s Request for Production No. 168 by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 273 SEALED Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding response to defendants' March 24, 2009 letter - re #271 Letter. (Attachments: #1 Exhibit 1 & 2)(Noreika, Maryellen) |
Filing 272 MOTION for Pro Hac Vice Appearance of Attorney Ketan Pastakia of Willkie Farr & Gallagher LLP - filed by Teva Pharmaceuticals USA Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 271 SEALED Letter to The Honorable Leonard P. Stark from Richard L. Horwitz regarding discovery dispute. (Horwitz, Richard) |
Filing 270 OBJECTIONS by Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc. to #264 REPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories HoldingREPORT AND RECOMMENDATIONS re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holding. (Attachments: #1 Exhibit 1)(Moore, David) |
Filing 269 Order Setting Teleconference: Discovery Telephone Conference set for 3/26/2009 03:00 PM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 3/19/2009. (rpg) |
SO ORDERED, re #267 MOTION for Pro Hac Vice Appearance of Attorney Breighanne A. Eggert of Katten Muchin Rosenman LLP filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 3/17/2009. (rpg) |
SO ORDERED, re #266 MOTION for Pro Hac Vice Appearance of Attorney Alexander L. Greenberg and Gregory A. Morris filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 3/17/2009. (rpg) |
Filing 268 NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Dr. Reddy's First Set of Interrogatories (No. 1) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 267 MOTION for Pro Hac Vice Appearance of Attorney Breighanne A. Eggert of Katten Muchin Rosenman LLP - filed by Apotex Inc., Apotex Corp.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 266 MOTION for Pro Hac Vice Appearance of Attorney Alexander L. Greenberg and Gregory A. Morris - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Motions referred to Leonard P. Stark.(Blumenfeld, Jack) |
Filing 265 NOTICE OF SERVICE of Plaintiffs' Second Set of Collective Requests for the Production of Documents and Things to Defendants (Nos. 66-68) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 264 REPORT AND RECOMMENDATION TO TRANSFER AND DISMISS AS MOOT re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Chemicals & Pharmaceuticals Ltd., #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Orgenus Pharma Inc., #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Objections to R&R due by 3/26/2009. Signed by Judge Leonard P. Stark on 3/9/2009. (rpg) |
Filing 263 NOTICE to Take Deposition of Adda C. Gogoris on April 22, 2009 at 9:00 a.m. by Upsher-Smith Laboratories Inc.. (Attachments: # 1 Exhibit 1 - Subpoena directed to Adda C. Gogoris)(Cottrell, Frederick) (Additional attachment(s) added on 3/5/2009: #2 Notice) (rpg). (Additional attachment(s) added on 3/5/2009: #3 Exhibit 1) (rpg). |
Filing 262 NOTICE to Take Deposition of S. Peter Ludwig on April 29, 2009 at 9:00 a.m. by Upsher-Smith Laboratories Inc.. (Attachments: # 1 Exhibit 1 - Subpoena directed to S. Peter Ludwig)(Cottrell, Frederick) (Additional attachment(s) added on 3/5/2009: #2 Notice) (rpg). (Additional attachment(s) added on 3/5/2009: #3 Exhibit 1) (rpg). |
Remark: PDF's docketed as d.i. #262 and #263 have been replaced to indicate the proper names' of the deponents noticed by counsel. (rpg) |
Filing 261 Joint STIPULATION - EXPERT DISCOVERY STIPULATION by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
SO ORDERED, re #261 Stipulation,,, filed by Merz Pharma GmbH & Co. KGaA, Amneal Pharmaceuticals, LLC, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Amneal Pharmaceuticals of New York LLC, Orchid Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Dr. Reddy's Laboratories Limited, Barr Pharmaceuticals Inc., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Interpharm Inc., PLIVA d.d., Orgenus Pharma Inc., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc. Signed by Judge Leonard P. Stark on 3/3/2009. (rpg) |
Filing 260 NOTICE OF SERVICE of Subpoenas to Take Depositon and to Produce Documents on Dr. Myron Weiner by Wockhardt USA Inc., Wockhardt Limited. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Farnan, Kelly) |
Filing 259 NOTICE OF SERVICE of Subpoenas to Take Deposition and to Produce Documents on Dr. Howard Fillit by Wockhardt USA Inc., Wockhardt Limited. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Farnan, Kelly) |
Filing 258 NOTICE OF SERVICE of Second Set of Requests for Production to Plaintiffs (No. 168) by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 257 NOTICE to Take Deposition of Wolfgang Schatton on April 16, 2009 by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Muttamara-Walker, Doungamon) |
Filing 256 NOTICE to Take Deposition of Joachim Bormann on April 14, 2009 by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Muttamara-Walker, Doungamon) |
Filing 255 NOTICE to Take Deposition of Markus R. Gold on April 15, 2009 by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Muttamara-Walker, Doungamon) |
Filing 254 NOTICE OF SERVICE of Plaintiffs' Objections and Response to Dr. Reddy's First Set of Interrogatories (No. 1) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
SO ORDERED, re #253 STIPULATION TO SUBSTITUTE PARTY AND AMEND CASE CAPTION by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Interpharm Holdings Inc., Interpharm Inc. Signed by Judge Leonard P. Stark on 1/20/2009. (rpg) |
Filing 253 STIPULATION TO SUBSTITUTE PARTY AND AMEND CASE CAPTION by Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals, LLC, Interpharm Holdings Inc., Interpharm Inc.. (Moore, David) |
Remark: Text in d.i. #252 altered to indicate that the document was not filed by Teva Pharmaceuticals USA Inc., and instead was filed by Barr Laboratories Inc.; Barr Pharmaceuticals Inc.; PLIVA d.d.; and PLIVA-HRVATSKA d.o.o. Teva Pharmaceuticals USA Inc.. (rpg) |
Filing 252 Disclosure Statement pursuant to Rule 7.1 filed by Barr Laboratories Inc.; Barr Pharmaceuticals Inc.; PLIVA d.d.; PLIVA-HRVATSKA d.o.o. (Moore, David) Modified on 1/14/2009 (rpg). |
Filing 251 NOTICE requesting Clerk to remove [the firm Kenyon & Kenyon as co-counsel. Reason for request: substitution of counsel with Willkie Farr & Gallagher entering its appearance for Teva Pharmaceuticals USA, Inc.. (Moore, David) |
Filing 250 NOTICE OF SUBSTITUTION OF COUNSEL re Teva Pharmaceuticals USA Inc.: Entry of appearance of attorney David Ellis Moore. Attorney Thomas G. Whalen, Jr. and Joseph H. Huston, Jr. of Stevens & Lee, P.C. terminated. (Moore, David) |
Filing 249 NOTICE OF SERVICE of Dr. Reddy's First Set of Interrogatories to Plaintiffs (No. 1) by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Horwitz, Richard) |
Filing 248 Official Transcript of Claim Construction Hearing held on Monday, December 15, 2008 before Magistrate Judge Stark. Court Reporter Brian Gaffigan, Telephone Number (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/12/2009. Redacted Transcript Deadline set for 1/22/2009. Release of Transcript Restriction set for 3/23/2009. (bpg) |
Filing 247 STENO NOTES of Markman Hearing held on 12/15/08 before Judge Stark. Court Reporter: B. Gaffigan. (Notes on file in Clerk's Office) (ntl) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing held on 12/15/2008. (Court Reporter B. Gaffigan.) (ntl) |
SO ORDERED, re #246 MOTION for Pro Hac Vice Appearance of Attorney Tara M. Raghavan filed by Cobalt Laboratories Inc. Signed by Judge Leonard P. Stark on 12/10/08. (ntl) |
Filing 246 MOTION for Pro Hac Vice Appearance of Attorney Tara M. Raghavan - filed by Cobalt Laboratories Inc.. Motions referred to Leonard P. Stark.(Matterer, Mary) |
CORRECTING ENTRY: Exhibit #10 in D.I. #244 REDACTED VERSION has been replaced with its corrected version at Exhibit #16. (asw) |
Filing 245 Amended ANSWER to #1 Complaint,, / First Amended Answer Of Defendant Teva Pharmaceuticals USA, Inc. by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certificate of Service)(Huston, Joseph) |
Filing 244 REDACTED VERSION of #241 Appendix,,,, VOLUME II OF II by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit B1-B8, #2 Exhibit B9 - B10, #3 Exhibit B11 - B16, #4 Exhibit B17, #5 Exhibit B18 - Part 1, #6 Exhibit B18 - Part 2, #7 Exhibit B19 - B24, #8 Exhibit B25, #9 Exhibit B26 - B29, # 10 Exhibit B30 - B40, #11 Exhibit C1 - C7, #12 Exhibit C8 - C10, #13 Exhibit C11, #14 Exhibit C12, #15 Exhibit Brauerman A-D)(Noreika, Maryellen) (Replacement attachment(s) #10 added on 12/10/2008: #16 B30 - B40) (asw). |
Filing 243 REDACTED VERSION of #240 Appendix,,,, VOLUME I OF II by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A1, #2 Exhibit A2 - Part 1, #3 Exhibit A2 - Part 2, #4 Exhibit A2 - Part 3, #5 Exhibit A2 - Part 4, #6 Exhibit A2 - Part 5, #7 Exhibit A2 - Part 6, #8 Exhibit A2 - Part 7, #9 Exhibit A2 - Part 8, #10 Exhibit A2 - Part 9, #11 Exhibit A3 - Part 1, #12 Exhibit A3 - Part 2, #13 Exhibit A3 - Part 3, #14 Exhibit A3 - Part 4, #15 Exhibit A3 - Part 5, #16 Exhibit A3 - Part 6, #17 Exhibit A3 - Part 7, #18 Exhibit A3 - Part 8, #19 Exhibit A3 - Part 9)(Noreika, Maryellen) |
Filing 242 SO ORDERED, re #239 MOTION to Amend/Correct It's Answer (Unopposed) filed by Teva Pharmaceuticals USA Inc.. Signed by Judge Leonard P. Stark on 12/2/2008. (rpg) |
Filing 241 SEALED APPENDIX re #223 Opening Brief in Support, #222 Claim Construction Opening Brief,, #235 Claim Construction Answering Brief, #236 Claim Construction Answering Brief JOINT APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE CITED IN THE PARTIES' CLAIM CONSTRUCTION BRIEFS (VOLUME II OF II) by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 240 SEALED APPENDIX re #223 Opening Brief in Support, #222 Claim Construction Opening Brief,, #235 Claim Construction Answering Brief, #236 Claim Construction Answering Brief JOINT APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE CITED IN THE PARTIES' CLAIM CONSTRUCTION BRIEFS (VOLUME I OF II) by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 239 MOTION to Amend/Correct It's Answer (Unopposed) - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Exhibit First Amended Answer, #2 Exhibit B - First Amended Answer, #3 Certificate of Service)Motions referred to Leonard P. Stark.(Huston, Joseph) |
Filing 238 REDACTED VERSION of #227 Letter to The Honorable Leonard P. Stark from David E. Moore regarding 28 U.S.C. Section 1631 and Plaintiffs' Motion to Transfer by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc.. (Attachments: #1 Exhibit A-B)(Moore, David) |
Filing 237 DECLARATION re #236 Claim Construction Answering Brief by Lupin Pharmaceuticals Inc., Lupin Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Certificate of Service)(Brauerman, Stephen) |
Filing 236 Joint CLAIM CONSTRUCTION ANSWERING BRIEF on Behalf of All Defendants filed by Lupin Pharmaceuticals Inc., Lupin Ltd.. (Attachments: #1 Certificate of Service)(Kirk, Richard) |
Filing 235 CLAIM CONSTRUCTION ANSWERING BRIEF re #222 Claim Construction Opening Brief,, filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 234 STATEMENT Plaintiffs' Answer to Defendant Mylan Pharmaceutical Inc.'s Amended Counterclaims by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 233 STATEMENT Plaintiffs' Answer To Defendants Genpharm Inc.'s and Genpharm, L.P.'s Amended Counterclaims by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 232 STATEMENT Plaintiffs' Answer To Defendant Sun India Pharmaceutical Industries Limited's Amended Counterclaims by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 231 ANSWER to #94 Answer to Complaint, Counterclaim of Apotex Inc. and Apotex Corp. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 230 ANSWER to #47 Answer to Complaint, Counterclaim,, of Cobalt Laboratories Inc.'s by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
SO ORDERED, re #229 Stipulation filed by Lupin Ltd., Lupin Pharmaceuticals Inc., Set Briefing Schedule: ( Claim Construction Answering Briefs due on or before 11/24/2008 ). Signed by Judge Leonard P. Stark on 11/20/2008. (rpg) |
Filing 229 STIPULATION and Order Extending Briefing by Lupin Pharmaceuticals Inc., Lupin Ltd.. (Kirk, Richard) |
Filing 228 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding supplemental briefing on transfer statute and Court's ruling on plaintiffs' contingent cross-motion to transfer. (Attachments: #1 Exhibit A)(Blumenfeld, Jack) |
Filing 227 SEALED Letter to The Honorable Leonard P. Stark from David E. Moore regarding 28 U.S.C. Section 1631 and Plaintiffs' Motion to Transfer. (Moore, David) |
Filing 226 Transcript of Oral Argument/Technology Tutorial held on 11/12/08 before Judge Stark. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/5/2008. Redacted Transcript Deadline set for 12/15/2008. Release of Transcript Restriction set for 2/12/2009. (kjm) Modified on 11/17/2008 (ntl). |
SO ORDERED, re #220 MOTION for Pro Hac Vice Appearance of Attorney Richard W. Ward filed by Teva Pharmaceuticals USA Inc.. Signed by Judge Leonard P. Stark on 11/12/2008. (rpg) |
SO ORDERED, re #221 MOTION for Pro Hac Vice Appearance of Attorney Lee B. Shelton filed by Teva Pharmaceuticals USA Inc.. Signed by Judge Leonard P. Stark on 11/12/2008. (rpg) |
SO ORDERED, re #225 Stipulation [STIPULATED AMENDMENT TO PROTECTIVE ORDER], filed by PLIVA-HRVATSKA d.o.o., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Dr. Reddy's Laboratories Inc., Orchid Chemicals & Pharmaceuticals Ltd., Barr Pharmaceuticals Inc., Dr. Reddy's Laboratories Limited, Orchid Pharmaceuticals Inc., PLIVA d.d., Interpharm Inc., Orgenus Pharma Inc., Genpharm Inc., Barr Laboratories Inc. Signed by Judge Leonard P. Stark on 11/12/2008. (rpg) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Oral Argument/Technology Tutorial held on 11/12/2008. (Court Reporter K. Maurer.) (ntl) |
Filing 225 STIPULATION [STIPULATED AMENDMENT TO PROTECTIVE ORDER] re #195 SO ORDERED,,, #196 Order, by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Apotex Inc., Apotex Corp.. (Moore, David) |
Filing 224 DECLARATION re #223 Opening Brief in Support, of Their Proposed Claim Constructions (of Steven H. Ferris, Ph.D.) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Noreika, Maryellen) |
Filing 223 OPENING BRIEF in Support of Their Proposed Claim Constructions filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.Answering Brief/Response due date per Local Rules is 12/1/2008. (Noreika, Maryellen) |
Filing 222 CLAIM CONSTRUCTION OPENING BRIEF filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp.. (Moore, David) |
Filing 221 MOTION for Pro Hac Vice Appearance of Attorney Lee B. Shelton - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certification of Lee B. Shelton)Motions referred to Leonard P. Stark.(Huston, Joseph) |
Filing 220 MOTION for Pro Hac Vice Appearance of Attorney Richard W. Ward - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certification of Richard W. Ward)Motions referred to Leonard P. Stark.(Huston, Joseph) |
Filing 219 ORDER granting #217 Motion to Amend/Correct. ( The Amended Pleadings attached to the motions as Exhibits A-E are deemed file and served as of the Order ). Signed by Judge Leonard P. Stark on 11/6/2008. (rpg) |
SO ORDERED, re #218 Stipulation, filed by PLIVA-HRVATSKA d.o.o., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Dr. Reddy's Laboratories Inc., Orchid Chemicals & Pharmaceuticals Ltd., Barr Pharmaceuticals Inc., Dr. Reddy's Laboratories Limited, Orchid Pharmaceuticals Inc., PLIVA d.d., Interpharm Inc., Orgenus Pharma Inc., Genpharm Inc., Barr Laboratories Inc. Signed by Judge Leonard P. Stark on 11/5/2008. (rpg) |
Filing 218 STIPULATION To Amend Protective Order (filed on behalf of all parties) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Apotex Inc., Apotex Corp.. (Moore, David) |
Filing 217 MOTION to Amend/Correct (DEFENDANTS' UNOPPOSED MOTION FOR LEAVE TO AMEND ANSWERS) - filed by Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc., Apotex Inc., Apotex Corp.. (Attachments: #1 Exhibit A (Cobalt Amended Answer), #2 Exhibit B (Sun Amended Answer), #3 Exhibit C (Apotex Amended Answer), #4 Exhibit D (Mylan Amended Answer), #5 Exhibit E (Genpharm Amended Answer), #6 Exhibit F (Cobalt Blackline), #7 Exhibit G (Sun Blackline), #8 Exhibit H (Apotex Blackline), #9 Exhibit I (Mylan Blackline), #10 Exhibit J (Genpharm Blackline), #11 Text of Proposed Order)Motions referred to Leonard P. Stark.(Moore, David) |
Filing 216 NOTICE OF SERVICE of Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma Inc.'s First Supplemental Responses and Objections to Plaintiffs' First Set of Collective Request for the Production of Documents and Things to Defendants; and Orchid Pharmaceuticals Inc.'s First Supplemental Responses and Objections to Plaintiffs' First Set of Collective Request for the Production of Documents and Things to Defendants by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Moore, David) |
Filing 215 AMENDED ORDER Re-setting Scheduling Order Deadlines ( Claims Construction Opening Brief due by 11/7/2008, Claim Construction Reply Brief due 11/21/2008 ). Signed by Judge Leonard P. Stark on 10/29/2008. (rpg) |
Filing 214 Letter to The Honorable Leonard P. Stark from Richard K. Herrmann regarding the Due Date for Claim Construction Briefs - re #213 Order on Motion for Leave to File Excess Pages,,,. (Herrmann, Richard) |
Filing 213 ORDER granting #211 Motion for Leave to File Excess Pages (unopposed) - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp. ( Please see Order for complete details ). Signed by Judge Leonard P. Stark on 10/28/2008. (rpg) |
Filing 212 NOTICE OF SERVICE of Objections and Responses to Defendants' First Set of Interrogatories Directed to Common Discovery Issues by Forest Laboratories Inc., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 211 MOTION for Leave to File Excess Pages (unopposed) - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp.. Motions referred to Leonard P. Stark.(Matterer, Mary) |
Filing 210 NOTICE of Service of Defendant Teva Pharmaceuticals USA, Inc.'s Responses and Objections to Plaintiffs' First Set of Collective Interrogatories by Teva Pharmaceuticals USA Inc. (Huston, Joseph) |
Filing 209 NOTICE OF SERVICE of Responses to Plaintiffs' First Set of Collective Interrogatories by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 208 NOTICE OF SERVICE of Responses and Objections of Defendants Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc. and Orchid Pharmaceuticals Inc. to Plaintiffs' First Set of Collective Interrogatories (Nos. 1-7) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Moore, David) |
Filing 207 NOTICE OF SERVICE of Defendants Interpharm Holdings, Inc.'s, Interpharm, Inc.'s, Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Objections and Responses to Plaintiffs' First Set of Collective Interrogatories (Nos. 1-7) by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Interpharm Holdings Inc., Interpharm Inc..(Moore, David) |
Filing 206 NOTICE OF SERVICE of Objections and Answers to Plaintiffs' First Set of Collective Interrogatories by Sun India Pharmaceutical Industries Limited.(Seaman, John) |
Filing 205 NOTICE OF SERVICE of Objections and Responses to Plaintiff Forest's First Set of Collective Interrogatories (Nos. 1-7) by Wockhardt USA Inc., Wockhardt Limited.(Farnan, Kelly) |
Filing 204 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Responses and Objections to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-7) and Defendants Genpharm ULC and Genpharm L.P.'s Responses and Objections to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-7) by Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc..(Moore, David) |
Filing 203 NOTICE OF SERVICE of Defendant's Answers and Objections to Plaintiffs' First Set of Collective Interrogatories by Apotex Inc., Apotex Corp..(Moore, David) |
Filing 202 NOTICE OF SERVICE of Defendant Upsher-Smith Laboratories, Inc.'s Objections and Responses To Plaintiffs' First Set of Interrogatories re #164 Notice of Service by Upsher-Smith Laboratories Inc.. Related document: #164 Notice of Service filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH.(Gaza, Anne) |
Filing 201 NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' First Set of Interrogatories by Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA-HRVATSKA d.o.o..(Moore, David) |
Filing 200 NOTICE OF SERVICE of Defendant Lupin Pharmaceuticals Inc. and Lupin Ltd.'s Objections and Responses to Plaintiffs' First Set of Collective Interrogatories by Lupin Pharmaceuticals Inc., Lupin Ltd..(Kirk, Richard) |
Filing 199 NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' Combined Requests for Production Nos. 117-167 by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 198 CLAIM Construction Chart by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 197 Letter to THE HONORABLE LEONARD P. STARK from DAVID E. MOORE, ESQ. regarding DEFENDANTS 'LETTER RE JOINT CLAIM CONSTRUCTION CHART. (Moore, David) |
Filing 196 ORDER Regarding Status of Orchid and Orgenus re #194 Letter Regarding response to Orchid and Orgenus's October 8, 2008 letter, #190 Letter regarding status of Orchid and Orgenus. ( Please see Order for complete details related to Letter Requests ). Signed by Judge Leonard P. Stark on 10/16/2008. (rpg) |
Filing 195 SO ORDERED, re #193 Stipulation,, filed by Merz Pharma GmbH & Co. KGaA, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Barr Pharmaceuticals Inc., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Interpharm Inc., PLIVA d.d., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc. ( Please see attached Order for complete details ). Signed by Judge Leonard P. Stark on 10/14/2008. (rpg) |
Filing 194 Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding response to Orchid and Orgenus's October 8, 2008 letter - re #190 Letter. (Noreika, Maryellen) |
Filing 193 Joint STIPULATION Stipulated Protective Order Pursuant to Federal Rule of Civil Procedure 26(c) by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
SO ORDERED, re #192 STIPULATION TO EXTEND TIME for plaintiffs' to file their response to Orchid's and Orgenus' October 8, 2008 letter (D.I. 190) to October 14, 2008 STIPULATION TO EXTEND TIME for plaintiffs' to file their response to Orchid's and Orgenus' October 8, 2008 letter (D.I. 190) to October 14, 2008 filed by Merz Pharma GmbH & Co. KGaA, Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Orgenus Pharma Inc.. Signed by Judge Leonard P. Stark on 10/10/2008. (rpg) |
Filing 192 STIPULATION TO EXTEND TIME for plaintiffs' to file their response to Orchid's and Orgenus' October 8, 2008 letter (D.I. 190) to October 14, 2008 - filed by Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Inc., Orgenus Pharma Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 191 REDACTED VERSION of #188 Reply Brief, re 43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] [SUPPLEMENTAL REPLY BRIEF OF DEFENDANT ORCHID CHEMICALS & PHARMACEUTICALS LTD IN FURTHER SUPPORT OF ITS MOTION TO DISM ISS FOR LACK OF PERSONAL JURISDICTION] by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Attachments: #1 Exhibit 1 part 1, #2 Exhibit 1 part 2, #3 Exhibit 2)(Moore, David) |
Filing 190 Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding status of Orchid and Orgenus. (Attachments: #1 Text of Proposed Order, #2 Exhibit A-C)(Moore, David) |
SO ORDERED, re #189 STIPULATION TO EXTEND TIME to file proposed Protective Order to October 10, 2008 filed by Merz Pharma GmbH & Co. KGaA, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Orchid Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Dr. Reddy's Laboratories Limited, Barr Pharmaceuticals Inc., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Interpharm Inc., PLIVA d.d., Orgenus Pharma Inc., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc.. Signed by Judge Leonard P. Stark on 10/6/2008. (rpg) |
Filing 189 STIPULATION TO EXTEND TIME to file proposed Protective Order to October 10, 2008 - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
Filing 188 SEALED REPLY BRIEF re #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] [SUPPLEMENTAL REPLY BRIEF OF DEFENDANT ORCHID CHEMICALS & PHARMACEUTICALS LTD IN FURTHER SUPPORT OF ITS MOTION TO DISMISS FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Moore, David) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 9/26/2008. (Court Reporter K. Maurer.) (ntl) |
Filing 187 Letter to The Honorable Leonard P. Stark from Richard D. Kirk regarding Protective Order. (Attachments: #1 Protective Order, #2 Certificate of Service)(Kirk, Richard) |
Filing 186 REDACTED VERSION of #165 Answering Brief in Opposition, Plaintiffs' Supplemental Brief in Opposition to Defendant Orchid India's Motion to Dismiss for Lack of Personal Jurisdiction by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1-21)(Noreika, Maryellen) |
Filing 185 Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding protective order. (Attachments: #1 Text of Proposed Order Stipulated Protective Order)(Noreika, Maryellen) |
Filing 184 NOTICE of Service by Teva Pharmaceuticals USA Inc. (Attachments: #1 Certificate of Service)(Huston, Joseph) |
Filing 183 NOTICE OF SERVICE of Response of Wockhardt USA, Inc. and Wockhardt Limited to Plaintiffs' First Set of Collective Requests for Production of Documents and Things by Wockhardt USA Inc., Wockhardt Limited.(Moyer, Jeffrey) |
Filing 182 NOTICE OF SERVICE of 1) Plaintiffs' Response to DRL Laboratories Inc.'s First Set of Requests for Production (Nos. 1-116); and 2) Plaintiffs' Response to Cobalt Laboratories Inc.'s First Set of Requests for Production (Nos. 1-116) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 181 NOTICE OF SERVICE of Responses to Plaintiffs' First Set of Collective Requests for Production of Documents by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Horwitz, Richard) |
Filing 180 NOTICE OF SERVICE of Responses to Plaintiffs' First Set of Collective Requests for Production of Documents by Interpharm Holdings Inc., Interpharm Inc..(Horwitz, Richard) |
Filing 179 REPLY BRIEF re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibits 1-2)(Noreika, Maryellen) |
Filing 178 NOTICE OF SERVICE of Response to Plaintiffs' First Set of Collective Requests for Production of Documents by Sun India Pharmaceutical Industries Limited.(Seaman, John) |
Filing 177 NOTICE OF SERVICE of Response of Upsher-Smith Laboratories, Inc. to Plaintiffs' First Set of Collective Requests For Production of Documents by Upsher-Smith Laboratories Inc..(Gaza, Anne) |
Filing 176 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things by Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA-HRVATSKA d.o.o..(Horwitz, Richard) |
Filing 175 NOTICE OF SERVICE of Response of Lupin Pharmaceuticals, Inc. and Lupin Limited to Plaintiffs' First Set of Collective Requests for Production of Documents by Lupin Ltd..(Kirk, Richard) |
Filing 174 NOTICE OF SERVICE of Defendants Genpharm ULC and Genpharm LP's Objections and Responses to Plaintiffs' First Set of Collective Requests for the Production of Documents and Things to Defendants (Nos. 1-65); and Defendants Mylan Pharmaceuticals, Inc.'s Responses and Objections to Plaintiffs' First Set of Collective Requests for the Production of Documents and Things to Defendants (Nos. 1-65) by Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc..(Horwitz, Richard) |
Filing 173 NOTICE OF SERVICE of Responses and Objections to Plaintiffs' First Set of Collective Requests for the Production of Documents and Things by Apotex Inc., Apotex Corp..(Horwitz, Richard) |
Filing 172 NOTICE OF SERVICE of Objections and Responses to Plaintiffs' First Set of Collective Requests for the Production of Documents and Things to Defendants by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 171 Order Setting Teleconference: Discovery Telephone Conference set for 9/26/2008 03:00 PM before Judge Leonard P. Stark. ( Please see Order for details regarding letter submissions ). Signed by Judge Leonard P. Stark on 9/19/2008. (rpg) |
SO ORDERED granting the parties' request to amend paragraph 3 of the Scheduling Order, re #166 Proposed Order to amend paragraph 3 of the Scheduling Order filed by Cobalt Laboratories Inc. Final Joint Claim Chart shall now be due on or before 10/17/2008 AND Opening Claim Construction Briefs are now due on or before 11/7/2008. The remaining provisions of the Scheduling Order shall remain unchanged. Signed by Judge Leonard P. Stark on 9/19/2008. (rpg) |
Filing 170 NOTICE OF SERVICE of Defendants First Set of Interrogatories Directed to Common Discovery Issues to be Served on Behalf of the Defendants Apotex Inc.; Apotex Corp.; Barr Laboratories, Inc.; Barr Pharmaceuticals, Inc.; PLIVA-Hrvatska d.o.o.; Cobalt Laboratories Inc.; Dr. Reddy's Laboratories, Inc.; Dr. Reddy's Laboratories, Ltd.; Genpharm ULC (Successor to Genpharm Inc.); Genpharm, L.P.; Interpharm Holdings, Inc.; Interpharm, Inc.; Lupin Pharmaceuticals, Inc.; Lupin Limited; Mylan Pharmaceuticals Inc.; Sun India Pharmaceutical Industries Limited (a/k/a Sun Pharmaceutical Industries, Inc.); Teva Pharmaceuticals USA, Inc.; Upsher-Smith Laboratories Inc.; Wockhardt USA, Inc.; and Wockhardt Limited (collectively, Defendants) re #117 Order, Set Deadlines/Hearings,,,, #114 Scheduling Order,,, by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp.. Related document: #117 Order, Set Deadlines/Hearings,,,, #114 Scheduling Order,,,.(Seaman, John) |
Filing 169 REDACTED VERSION of #163 Reply Brief re 87 MOTION to Dismiss for Lack of Jurisdiction Over the Person by Orgenus Pharma Inc.. (Attachments: #1 Exhibit 1-8)(Moore, David) |
Filing 168 REDACTED VERSION of #162 Answering Brief in Opposition, re 99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) by Orgenus Pharma Inc.. (Moore, David) |
Filing 167 NOTICE OF SERVICE of Defendants Apotex Inc., Barr Laboratories, Inc., Barr Pharmaceuticals Inc., Pliva-Hrvatska D.O.O., Cobalt Laboratories Inc., Genpharm ULC, Genpharm L.P., Interpharm Holdings, Inc., Interpharm Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., Sun India Pharmaceutical Industrise Limited (a/k/a Sun Pharmaceutical Industrise Ltd.), Teva Pharmaceuticals USA, Inc., Upsher-Smith Laboratories, Inc., Wockhardt USA Inc. and Wockhardt Limited's Requests For Production of Documents, Electronoically Stored Information, and Tangible Things to Plaintiffs by Upsher-Smith Laboratories Inc..(Gaza, Anne) |
Filing 166 Proposed PROPOSED ORDER Stipulated Revised Scheduling Order by Cobalt Laboratories Inc.. (Matterer, Mary) |
Filing 165 SEALED ANSWERING BRIEF in Opposition re #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.Reply Brief due date per Local Rules is 9/26/2008. (Attachments: #1 Exhibits 1-21)(Noreika, Maryellen) |
Filing 164 NOTICE OF SERVICE of Plaintiffs' First Set of Collective Interrogatories by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 163 SEALED REPLY BRIEF re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Orgenus Pharma Inc.. (Moore, David) |
Filing 162 SEALED ANSWERING BRIEF in Opposition re #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) filed by Orgenus Pharma Inc..Reply Brief due date per Local Rules is 9/22/2008. (Moore, David) |
SO ORDERED, re #161 Joint STIPULATION TO EXTEND TIME to file proposed Protective Order to September 17, 2008 filed by Merz Pharma GmbH & Co. KGaA, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Orchid Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Orchid Pharmaceuticals Inc., Interpharm Inc., PLIVA d.d., Orgenus Pharma Inc., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc.. Signed by Judge Leonard P. Stark on 9/11/2008. (rpg) |
Filing 161 Joint STIPULATION TO EXTEND TIME to file proposed Protective Order to September 17, 2008 - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
Filing 160 ORDER Setting Hearings on Motions for 11/12/2008 at 1:00 PM re #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Chemicals & Pharmaceuticals Ltd., #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Orgenus Pharma Inc., #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, ORDER Setting Hearing on Motion #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey, #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION], #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person, #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) :( Motion Hearing set for 11/12/2008 01:00 PM in Courtroom 2A before Judge Leonard P. Stark ). ( Please see Order for complete details ). Signed by Judge Leonard P. Stark on 9/9/2008. (rpg) |
Filing 159 NOTICE OF SERVICE of [Responses and Objections to Plaintiffs' First Set of Collective Requests for the Production of Documents and Things to Defendants] by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Moore, David) |
SO ORDERED, re #158 Stipulation GRANTING Request to file Supplemental Briefing in Connection with Defendant Orchid India's Motion to Dismiss, filed by Merz Pharma GmbH & Co. KGaA, Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH. Plaintiffs' brief due on or before 9/17/2008 and limited to five (5) pages. Orchid India shall be permitted to file a Supplemental Reply brief due on or before 10/1/2008 and limited to five (5) pages. Signed by Judge Leonard P. Stark on 9/3/2008. (rpg) |
Set Supplemental Briefing Schedule: re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person. Plaintiffs' Supplemental Brief due on or before 9/17/2008. Orchid India's Supplemental Reply Brief due on or before 10/1/2008. (rpg) |
SO ORDERED, re #154 MOTION for Pro Hac Vice Appearance of Attorney Colin C. Heitzmann filed by Sun India Pharmaceutical Industries Limited. Signed by Judge Leonard P. Stark on 9/3/2008. (rpg) |
SO ORDERED, re #157 STIPULATION TO EXTEND TIME Reply Brief on its Motion to Dismiss for Lack of Personal Jurisdiction to September 11, 2008 filed by Orgenus Pharma Inc. Set Briefing Schedule: re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person. ( Reply Brief due 9/11/2008 ). Signed by Judge Leonard P. Stark on 9/3/2008. (rpg) |
Filing 158 STIPULATION AND ORDER GRANTING PERMISSION TO FILE SUPPLEMENTAL BRIEFING IN CONNECTION WITH DEFENDANT ORCHID INDIA'S MOTION TO DISMISS by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 157 STIPULATION TO EXTEND TIME Reply Brief on its Motion to Dismiss for Lack of Personal Jurisdiction to September 11, 2008 - filed by Orgenus Pharma Inc.. (Moore, David) |
Filing 156 REDACTED VERSION of #152 Answering Brief in Opposition, Plaintiffs' Answering Brief in Opposition to Defendant Orgenus' Motion to Dismiss for Lack of Personal Jurisdiction by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1-4, #2 Exhibit 5 - part 1 of 2, #3 Exhibit 5, part 2 of 2, #4 Exhibit 6-25)(Noreika, Maryellen) |
Filing 155 REDACTED VERSION of #153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 154 MOTION for Pro Hac Vice Appearance of Attorney Colin C. Heitzmann - filed by Sun India Pharmaceutical Industries Limited. Motions referred to Leonard P. Stark.(Seaman, John) |
Filing 153 SEALED MOTION Contingent Cross-Motion to Transfer Their Claims Against Defendant Orgenus to United States District Court for the District of New Jersey - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Motions referred to Leonard P. Stark.(Noreika, Maryellen) |
Filing 152 SEALED ANSWERING BRIEF in Opposition re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.Reply Brief due date per Local Rules is 9/2/2008. (Attachments: #1 Exhibits 1 through 25)(Noreika, Maryellen) |
Filing 151 NOTICE OF SERVICE of Plaintiffs' First Set of Collective Requests for the Production of Documents and Things to Defendants by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 150 NOTICE OF SERVICE of Supplemental Response and Objections to Plaintiffs' Request for Admission No. 15 in Connection with Jurisdictional Discovery from the Orchid Defendants; and Supplemental Objections and Responses to Plaintiffs' Interrogatories Nos. 2 and 5 in Connection with Jurisdictional Discovery from the Orchid Defendants by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd..(Moore, David) |
Filing 149 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s First Set of Requests For Production to Plaintiffs (Nos. 1-116) by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Moore, David) |
SO ORDERED, re #148 Joint STIPULATION TO EXTEND TIME for Parties to File Proposed Protective Order to September 10, 2008 filed by Merz Pharma GmbH & Co. KGaA, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Orchid Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Dr. Reddy's Laboratories Limited, Barr Pharmaceuticals Inc., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Interpharm Inc., PLIVA d.d., Orgenus Pharma Inc., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc.. Signed by Judge Leonard P. Stark on 8/14/2008. (rpg) |
Filing 148 Joint STIPULATION TO EXTEND TIME for Parties to File Proposed Protective Order to September 10, 2008 - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
Filing 147 NOTICE OF SERVICE of Plaintiffs' First Set of Collective Requests for the Production of Documents and Things to Defendants by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 146 REPLY BRIEF re #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 32-34)(Noreika, Maryellen) |
Filing 145 NOTICE OF SERVICE of First Set of Requests for Production to Plaintiff (Nos. 1-116) by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 144 REDACTED VERSION of #135 Appendix, To Defendants' Reply Brief To Plaintiffs Opposition To Defendants' Motion To Dismiss For Lack Of Personal Jurisdiction (VOLUME 2 OF 2) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Attachments: #1 Exhibit 11-15, #2 Exhibit 16-18, #3 Exhibit 19-21, #4 Exhibit 22-25)(Moore, David) |
Filing 143 REDACTED VERSION of #134 Appendix, To Defendants' Reply Brief To Plaintiffs Opposition To Defendants' Motion To Dismiss For Lack Of Personal Jurisdiction (VOLUME 1 OF 2) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Attachments: #1 Exhibit 1-10)(Moore, David) |
Filing 142 REDACTED VERSION of #133 Brief (Combined Answering and Reply), Brief (Combined Answering and Reply), Brief (Combined Answering and Reply), Brief (Combined Answering and Reply) (Combined Answering and Reply) (SEALED COMBINED ANSWERING BRIEF IN OPPOSITION TO PLAINTIFFS' CONTINGENT MOTION TO TRANSFER AND REPLY BRIEF IN FURTHER SUPPORT OF DEFENDANTS' MOTION TO DISMISS FOR LACK OF PERSONAL JURISDICTION) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Moore, David) |
SO ORDERED, re #120 MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez of Budd Larner, P.C. filed by Interpharm Holdings Inc., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Interpharm Inc. Signed by Judge Leonard P. Stark on 7/29/2008. (rpg) |
SO ORDERED, re #141 STIPULATION TO EXTEND TIME for the parties to submit their proposed Protective Order to August 11, 2008 filed by Merz Pharma GmbH & Co. KGaA, PLIVA-HRVATSKA d.o.o., Forest Laboratories Holdings Ltd., Wockhardt USA Inc., Apotex Inc., Apotex Corp., Mylan Pharmaceuticals Inc., Interpharm Holdings Inc., Genpharm LP, Teva Pharmaceuticals USA Inc., Orchid Chemicals & Pharmaceuticals Ltd., Dr. Reddy's Laboratories Inc., Wockhardt Limited, Dr. Reddy's Laboratories Limited, Barr Pharmaceuticals Inc., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Interpharm Inc., PLIVA d.d., Orgenus Pharma Inc., Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Sun India Pharmaceutical Industries Limited, Upsher-Smith Laboratories Inc., Genpharm Inc., Barr Laboratories Inc. Signed by Judge Leonard P. Stark on 7/29/2008. (rpg) |
Filing 141 STIPULATION TO EXTEND TIME for the parties to submit their proposed Protective Order to August 11, 2008 - filed by Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited, Forest Laboratories Inc., Orgenus Pharma Inc., Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o., Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Genpharm Inc., Genpharm LP, Interpharm Holdings Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., Sun India Pharmaceutical Industries Limited, Apotex Inc., Apotex Corp., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Matterer, Mary) |
Filing 140 NOTICE OF SERVICE of Orgenus Pharma Inc.'s Objections and Responses to Plaintiffs' Requests for Admission in Connection with Jurisdictional Discovery and Orgenus Pharma Inc.'s Objections and Responses to Plaintiffs' Interrogatories in Connection with Jurisdictional Discovery by Orgenus Pharma Inc..(Moore, David) |
Filing 139 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant Orgenus' First Set of Interrogatories to Plaintiffs by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 138 NOTICE OF SERVICE of Defendant Upsher-Smith Laboratories, Inc.'s Initial Disclosures Under Rule 26(a)(1), Fed.R.Civ.P. by Upsher-Smith Laboratories Inc..(Gaza, Anne) |
Filing 137 NOTICE of Service by Teva Pharmaceuticals USA Inc. RE: Initial Disclosures under Fed. R. Civ. P. 26(a)(1) (Attachments: #1 Certificate of Service)(Huston, Joseph) |
Filing 136 NOTICE OF SERVICE of Lupin Pharmaceuticals, Inc.'s and Lupin Limited's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) by Lupin Pharmaceuticals Inc., Lupin Ltd..(Kirk, Richard) |
CORRECTING ENTRY: The pdf document in D.I. 131, Notice of Service has been deleted from the docket. The corrected version has been filed - SEE D.I. 132, Notice of Service. (asw) |
Filing 135 SEALED APPENDIX To Defendants' Reply Brief To Plaintiffs Opposition To Defendants' Motion To Dismiss For Lack Of Personal Jurisdiction (VOLUME 2 OF 2) (D.I. 133) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Moore, David) |
Filing 134 SEALED APPENDIX To Defendants' Reply Brief To Plaintiffs Opposition To Defendants' Motion To Dismiss For Lack Of Personal Jurisdiction (VOLUME 1 OF 2) (D.I. 133) by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Moore, David) |
Filing 133 BRIEF (Combined Answering and Reply) (SEALED COMBINED ANSWERING BRIEF IN OPPOSITION TO PLAINTIFFS' CONTINGENT MOTION TO TRANSFER AND REPLY BRIEF IN FURTHER SUPPORT OF DEFENDANTS' MOTION TO DISMISS FOR LACK OF PERSONAL JURISDICTION) re #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer), #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd..Reply Brief due date per Local Rules is 8/1/2008. (Moore, David) |
Filing 132 NOTICE OF SERVICE of Initial Disclosures by Sun India Pharmaceutical Industries Limited.(Seaman, John) |
Filing 131 NOTICE OF SERVICE of Initial Disclosures by Sun India Pharmaceutical Industries Limited.(Seaman, John) PLEASE DISREGARD THIS ENTRY - SEE CORRECTED VERSION AT D.I. 132. |
Filing 130 NOTICE OF SERVICE of Rule 26 Initial Disclosures by Genpharm Inc., Genpharm LP.(Horwitz, Richard) |
Filing 129 NOTICE OF SERVICE of Rule 26 Initial Disclosures by Mylan Pharmaceuticals Inc..(Horwitz, Richard) |
Filing 128 NOTICE OF SERVICE of Rule 26 Initial Disclosures by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Orgenus Pharma Inc..(Moore, David) |
Filing 127 NOTICE OF SERVICE of Initial Disclosures of Wockhardt Pursuant to Rule 26(a)(1) by Wockhardt USA Inc., Wockhardt Limited.(Farnan, Kelly) |
Filing 126 NOTICE OF SERVICE of Rule 26 Initial Disclosures by Barr Laboratories Inc., Barr Pharmaceuticals Inc., PLIVA d.d., PLIVA-HRVATSKA d.o.o..(Moore, David) |
Filing 125 NOTICE OF SERVICE of Rule 26 Initial Disclosures by Apotex Inc., Apotex Corp..(Moore, David) |
Filing 124 NOTICE OF SERVICE of Rule 26 Initial Disclosures by Interpharm Holdings Inc., Interpharm Inc..(Moore, David) |
Filing 123 NOTICE OF SERVICE of Rule 26 Initial Disclosures by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited.(Moore, David) |
Filing 122 NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures by Forest Laboratories Inc., Forest Laboratories Holdings Ltd..(Noreika, Maryellen) |
Filing 121 NOTICE OF SERVICE of Defendant Cobalt Laboratories Inc.'s Rule 26(a)(1) Initial Disclosures by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 120 MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez of Budd Larner, P.C. - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Limited, Interpharm Holdings Inc., Interpharm Inc.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 119 NOTICE OF SERVICE of Orgenus Pharma, Inc.'s Responses to Plaintiffs' Requests for the Production of Documents and Things in Connection with Jurisdictional Discovery by Orgenus Pharma Inc..(Moore, David) |
Filing 118 ANSWER to #94 Answer to Complaint, Counterclaim Plaintiffs' Reply to Defendants Apotex Inc.'s and Apotex Corp.'s Counterclaims by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 117 SUPPLEMENTAL SCHEDULING ORDER re #114 Scheduling Order, Setting ( Bench Trial set for 4/5/2010 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet, Bench Trial set for 4/6/2010 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet, Bench Trial set for 4/7/2010 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet, Bench Trial set for 4/8/2010 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet, Bench Trial set for 4/9/2010 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet ). Signed by Judge Leonard P. Stark on 7/17/2008. (rpg) |
SO ORDERED, re #116 STIPULATION TO EXTEND TIME regarding Orchid Chemicals & Pharmaceuticals Ltd.'s Combined Reply/Answering Brief on its Motion to Dismiss and Plaintiffs' Contingent Motion to Transfer by July 22, 2008; Plaintiffs' Reply Brief on their Cont filed by Orchid Chemicals & Pharmaceuticals Ltd., Orchid Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 7/17/2008. (rpg) |
Filing 116 STIPULATION TO EXTEND TIME regarding Orchid Chemicals & Pharmaceuticals Ltd.'s Combined Reply/Answering Brief on its Motion to Dismiss and Plaintiffs' Contingent Motion to Transfer by July 22, 2008; Plaintiffs' Reply Brief on their Contingent Motion to Transfer to August 5, 2008 - filed by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Horwitz, Richard) |
Filing 115 NOTICE OF SERVICE of Defendant Orgenus Pharma, Inc.'s Interrogatories to Plaintiffs Concerning Jurisdictional Issues by Orgenus Pharma Inc..(Moore, David) |
Filing 114 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/8/2008. Amended Pleadings due by 12/8/2008. Discovery due by 9/11/2009. In Chambers Status Conference set for 10/16/2009 10:00 AM in Courtroom 2A before Judge Leonard P. Stark. In Court Tutorial Describing the Technology and Matters in Issue set for 11/12/2008 1:00 PM. Claims Construction Opening Briefs due by 10/31/2008 and Claims Construction Answering Briefs due by 11/21/2008. Markman Hearing set for 12/15/2008 10:00 AM in Courtroom 2A before Judge Leonard P. Stark. Motions in Limine due by 1/6/2010. Responses to Motions in Limine due by 1/20/2010. Pretrial Conference set for 2/18/2010 10:00 AM in Chambers before Judge Leonard P. Stark. Proposed Pretrial Order due by 1/20/2010. 5 day Bench Trial set for TBD. ( Please see attached Order for complete details ). Signed by Judge Leonard P. Stark on 7/8/2008. (rpg) |
Filing 113 Letter to The Honorable Leonard P. Stark from Kelly E. Farnan regarding revised proposed scheduling order - re #104 Order. (Attachments: #1 Text of Proposed Order Proposed Scheduling Order)(Farnan, Kelly) |
Filing 112 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding revised proposed scheduling order - re #104 Order. (Attachments: #1 Text of Proposed Order)(Blumenfeld, Jack) |
Filing 111 NOTICE to Take Deposition of Orgenus Pharma, Inc.'s 30(b)(6) Designee on August 8, 2008 at 9:30 a.m. by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 110 NOTICE OF SERVICE of (i) Plaintiffs' Interrogatories in Connection with Jurisdictional Discovery from Orgenus, (ii) Plaintiffs' Requests for the Production of Documents and Things in Connection with Jurisdictional Discovery from Orgenus and (iii) Plaintiffs' Requests for Admission in Connection with Jurisdictional Discovery from Orgenus by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
SO ORDERED, re #106 Stipulation filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Orgenus Pharma Inc. Signed by Judge Leonard P. Stark on 7/7/2008. (rpg) |
Filing 109 REDACTED VERSION of #102 Appendix, Volume II of II by Forest Laboratories Inc., Forest Laboratories Holdings Ltd.. (Attachments: #1 Exhibits 6 through 17, #2 Exhibits 18 through 31)(Blumenfeld, Jack) |
Filing 108 REDACTED VERSION of #101 Appendix, Volume I of II by Forest Laboratories Inc., Forest Laboratories Holdings Ltd.. (Attachments: #1 Exhibits 1 through 3 (Part 1 of 2), #2 Exhibits 3 (Part 2 of 2) and 4, #3 Exhibit 5 (Part 1 of 3), #4 Exhibit 5 (Part 2 of 3), #5 Exhibit 5 (Part 3 of 3))(Blumenfeld, Jack) |
Filing 107 REDACTED VERSION of #100 Brief (Combined Opening and Answering), Brief (Combined Opening and Answering), Brief (Combined Opening and Answering) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd.. (Blumenfeld, Jack) |
Filing 106 STIPULATION Regarding Jurisdictional Discovery Schedule by Forest Laboratories Inc., Orgenus Pharma Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
SO ORDERED, re #105 STIPULATION TO EXTEND TIME Plaintiffs' deadline to respond to Orgenus' motion to dismiss to ten calendar days after the 30(b)(6) deposition of Orgenus STIPULATION TO EXTEND TIME Plaintiffs' deadline to respond to Orgenus' motion to dismiss to ten calendar days after the 30(b)(6) deposition of Orgenus filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Orgenus Pharma Inc.. Signed by Judge Leonard P. Stark on 7/3/2008. (rpg) |
Filing 105 STIPULATION TO EXTEND TIME Plaintiffs' deadline to respond to Orgenus' motion to dismiss to ten calendar days after the 30(b)(6) deposition of Orgenus - filed by Forest Laboratories Inc., Orgenus Pharma Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
Filing 104 ORDER Directing the Parties to Submit a Revised Proposed Scheduling Order to the Court by no later than 7/7/20078. ( Please see Order for complete details ). Signed by Judge Leonard P. Stark on 6/30/2008. (rpg) |
Filing 103 Transcript of Telephone Conference held on June 26, 2008 before Magistrate Judge Stark. Court Reporter Brian Gaffigan,Telephone number (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/21/2008. Redacted Transcript Deadline set for 7/31/2008. Release of Transcript Restriction set for 9/29/2008. (bpg) |
Filing 102 SEALED APPENDIX re #100 Brief (Combined Opening and Answering), Brief (Combined Opening and Answering), Brief (Combined Opening and Answering) VOLUME II OF II by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 6-31)(Blumenfeld, Jack) |
Filing 101 SEALED APPENDIX re #100 Brief (Combined Opening and Answering), Brief (Combined Opening and Answering), Brief (Combined Opening and Answering) VOLUME I OF II by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1-5)(Blumenfeld, Jack) |
Filing 100 BRIEF (Combined Opening and Answering) FILED UNDER SEAL re #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION], #99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.Answering Brief/Response due date per Local Rules is 7/17/2008. Reply Brief due date per Local Rules is 7/10/2008. (Blumenfeld, Jack) |
Filing 99 MOTION to Transfer Case to United States District Court for the District of New Jersey (Plaintiffs' Contingent Motion to Transfer) - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Motions referred to Leonard P. Stark.(Blumenfeld, Jack) |
SO ORDERED, re #93 MOTION for Pro Hac Vice Appearance of Attorney Renita S. Rathinam, Kim E. Choate and Chandran B. Iyer filed by Wockhardt Limited, Wockhardt USA Inc. Signed by Judge Leonard P. Stark on 6/27/2008. (rpg) |
Filing 98 Letter to The Hon. Leonard P. Stark from Kelly E. Farnan regarding June 26, 2008 scheduling conference - re Telephone Conference. (Farnan, Kelly) |
Filing 97 REDACTED VERSION of #90 Affidavit of Satish Srinivasan re 87 MOTION to Dismiss for Lack of Jurisdiction Over the Person by Orgenus Pharma Inc.. (Attachments: #1 Exhibit A-D)(Horwitz, Richard) |
Filing 96 REDACTED VERSION of #89 Opening Brief in Support re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person by Orgenus Pharma Inc.. (Horwitz, Richard) |
Filing 95 STENO NOTES of teleconference held on 6/26/08 before Judge Stark. Court Reporter: B. Gaffigan. (Notes on file in Clerk's Office) (ntl) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 6/26/2008. (Court Reporter B. Gaffigan.) (ntl) |
Filing 94 ANSWER to Complaint with Jury Demand, COUNTERCLAIM against Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH by Apotex Inc., Apotex Corp..(Moore, David) |
SO ORDERED, re #92 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler and Terrence J. Connolly of Latham & Watkins LLP filed by Orgenus Pharma Inc. Signed by Judge Leonard P. Stark on 6/24/2008. (rpg) |
Filing 93 MOTION for Pro Hac Vice Appearance of Attorney Renita S. Rathinam, Kim E. Choate and Chandran B. Iyer - filed by Wockhardt USA Inc., Wockhardt Limited. Motions referred to Leonard P. Stark.(Farnan, Kelly) |
Filing 92 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler and Terrence J. Connolly of Latham & Watkins LLP - filed by Orgenus Pharma Inc.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 91 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding enclosing proposed scheduling order for discussion during scheduling conference. (Attachments: #1 Text of Proposed Order Proposed Scheduling Order)(Blumenfeld, Jack) |
SO ORDERED, re #84 MOTION for Pro Hac Vice Appearance of Attorney Lorelei Westin of Wilson Sonsini Goodrich & Rosati filed by Genpharm LP, Genpharm Inc., Mylan Pharmaceuticals Inc., #80 MOTION for Pro Hac Vice Appearance of Attorney Andres Sawicki and Manuel Velez filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, #85 MOTION for Pro Hac Vice Appearance of Attorney Robert B. Briesblatt, Stephen P. Benson, Craig M. Kuchii, Brian J. Sodikoff, Jeremy C. Daniel and Joanna R. Stevason of Katten Muchin Rosenman LLP filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 6/23/08. (ntl) |
Filing 90 SEALED AFFIDAVIT of Satish Srinivasan re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Orgenus Pharma Inc.. (Horwitz, Richard) |
Filing 89 SEALED OPENING BRIEF in Support re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Orgenus Pharma Inc..Answering Brief/Response due date per Local Rules is 7/7/2008. (Horwitz, Richard) |
Filing 88 PROPOSED ORDER re #87 MOTION to Dismiss for Lack of Jurisdiction Over the Person by Orgenus Pharma Inc.. (Horwitz, Richard) |
Filing 87 MOTION to Dismiss for Lack of Jurisdiction Over the Person - filed by Orgenus Pharma Inc.. Motions referred to Leonard P. Stark.(Horwitz, Richard) |
Filing 86 ANSWER to Complaint PLAINTIFFS' REPLY TO DEFENDANTS INTERPHARM HOLDINGS, INC. AND INTERPHARM, INC.'S COUNTERCLAIMS by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 85 MOTION for Pro Hac Vice Appearance of Attorney Robert B. Briesblatt, Stephen P. Benson, Craig M. Kuchii, Brian J. Sodikoff, Jeremy C. Daniel and Joanna R. Stevason of Katten Muchin Rosenman LLP - filed by Apotex Inc., Apotex Corp.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 84 MOTION for Pro Hac Vice Appearance of Attorney Lorelei Westin of Wilson Sonsini Goodrich & Rosati - filed by Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc.. Motions referred to Leonard P. Stark.(Moore, David) |
CORRECTING ENTRY: D.I. 84, Motion for Pro Hac Vice, was filed in error and has been removed from the docket. Counsel shall immediately re-file the corrected version and the corrected version will be assigned D.I. 84. (asw) |
Filing 83 ORDER of Consolidation. Civ. No. 08-336-GMS-LPS is hereby Consolidated with Civ. No. 08-21-GMS-LPS and all Other Previously Consolidated cases. Signed by Judge Leonard P. Stark on 6/16/2008. (rpg) |
Filing 82 Order Setting Teleconference:( Rule 16 Telephone Conference set for 6/26/2008 10:00 AM before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 6/16/2008. (rpg) |
Filing 81 NOTICE OF SUBSTITUTION OF COUNSEL re Genpharm Inc., Genpharm LP, Mylan Pharmaceuticals Inc.: Entry of appearance of attorney David Ellis Moore. Attorney Firm of Balick & Balick, LLC terminated. (Moore, David) |
Filing 80 MOTION for Pro Hac Vice Appearance of Attorney Andres Sawicki and Manuel Velez - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Motions referred to Leonard P. Stark.(Blumenfeld, Jack) |
SO ORDERED, re #79 STIPULATION TO EXTEND TIME related to Orchid India's Motion to Dismiss to June 27 - Plaintiffs' response; July 17 - Orchid India's reply and 30(b)(6) postponed until June 13, 2008 STIPULATION TO EXTEND TIME related to Orchid India's Motion to Dismiss to June 27 - Plaintiffs' response; July 17 - Orchid India's reply and 30(b)(6) postponed until June 13, 2008 filed by Merz Pharma GmbH & Co. KGaA, Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 6/10/2008. (rpg) |
SO ORDERED, re #78 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to June 19, 2008 filed by Orgenus Pharma Inc. Signed by Judge Leonard P. Stark on 6/10/2008. (rpg) |
Filing 79 STIPULATION TO EXTEND TIME related to Orchid India's Motion to Dismiss to June 27 - Plaintiffs' response; July 17 - Orchid India's reply and 30(b)(6) postponed until June 13, 2008 - filed by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
Filing 78 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to June 19, 2008 - filed by Orgenus Pharma Inc.. (Horwitz, Richard) |
Filing 77 Order Setting Rule 16 Scheduling Teleconference: ( Telephone Conference set for 6/26/2008 10:00 AM before Judge Leonard P. Stark ). ( Please see Order for complete details ). Signed by Judge Leonard P. Stark on 6/2/2008. (rpg) |
Filing 76 ORDER OF CONSOLIDATION. Case Numbers 08-22-GMS-LPS, 08-52-GMS-LPS, and 08-291-GMS-LPS are hereby Consolidated into Case Number 08-21-GMS-LPS which shall serve as the lead case for this action. ( Please see Order for details ). Signed by Judge Leonard P. Stark on 6/2/2008. (rpg) Modified on 8/25/2008 (rpg). |
CORRECTING ENTRY: Replaced DI#75 with the corrected document. (maw) |
Filing 75 Transcript of Telephone Conference held on 5/20/08 before Judge Leonard P. Stark. Court Reporter/Transcriber Brian P. Gaffigan,Telephone number 302-573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/17/2008. Redacted Transcript Deadline set for 6/27/2008. Release of Transcript Restriction set for 8/25/2008. (bpg) (maw). |
Filing 74 Letter to The Honorable Leonard P. Stark from Richard L. Horwitz regarding consolidated scheduling order. (Horwitz, Richard) |
Filing 73 STENO NOTES of teleconference held on 5/20/08 before Judge Stark. Court Reporter: B. Gaffigan. (Notes on file in Clerk's Office) (ntl) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 5/20/2008. (Court Reporter B. Gaffigan.) (ntl) |
Filing 72 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to the Orchid Defendants' First Set of Interrogatories to Plaintiffs by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 71 NOTICE OF SERVICE of Orchid Chemicals and Phamraceuticals Ltd. and Orchid Parmaceuticals Inc.'s Responses and Objections to: Plaintiffs' Requests for the Production of Documents and Things in Connection with Jurisdictional Discovery from the Orchid Defendants, Plaintiffs' Interrogatories in Connection with the Jurisdictional Discovery from the Orchid Defendants, and Plaintiffs' Requests for Admission in Connection with the Jurisdictional Discovery from the Orchid Defendants. by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd..(Moore, David) |
Filing 70 Order Setting Status Teleconference:( Telephone Conference set for 5/20/2008 10:00 AM before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 5/1/2008. (rpg) |
Filing 69 NOTICE to Take Deposition of Orchid Chemical & Pharmaceuticals Ltd. in Connection with Jurisdictional Discovery pursuant to Rule 30(b)(6) on May 23, 2008 by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
SO ORDERED, re #68 MOTION for Pro Hac Vice Appearance of Attorney Michael M. Shen filed by Teva Pharmaceuticals USA Inc. Ordered by Chief Judge Gregory M. Sleet on 4/21/2008. (asw) |
SO ORDERED, re #65 MOTION for Pro Hac Vice Appearance of Attorney Mark Boland and Michael R. Dzwonczyk filed by Wockhardt Limited, Wockhardt USA Inc. Ordered by Chief Judge Gregory M. Sleet on 4/21/2008. (asw) |
Filing 68 MOTION for Pro Hac Vice Appearance of Attorney Michael M. Shen - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certification of Michael M. Shen, #2 Certificate of Service)Motions referred to Leonard P. Stark.(Whalen, Thomas) |
Filing 67 NOTICE OF SERVICE of Defendants Orchid Chemicals & Pharmaceuticals Ltd.'s and Orchid Pharmaceuticals Inc.'s First Set of Interrogatories to Plaintiffs by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd..(Moore, David) |
Filing 66 NOTICE OF SERVICE of (i) Plaintiffs' Interrogatories in Connection with Jurisdictional Discovery from Orchid Defendants; (ii) Plaintiffs' Requests for the Production of Documents and Things in Connection with Jurisdictional Discovery from Orchid Defendants and (iii) Plaintiffs' Requests for Admission in Connection with Jurisdictional Discovery from the Orchid Defendants by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Noreika, Maryellen) |
Filing 65 MOTION for Pro Hac Vice Appearance of Attorney Mark Boland and Michael R. Dzwonczyk - filed by Wockhardt USA Inc., Wockhardt Limited. Motions referred to Leonard P. Stark.(Farnan, Kelly) |
SO ORDERED, re #64 Stipulation, filed by Merz Pharma GmbH & Co. KGaA, Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Orchid Pharmaceuticals Inc., Merz Pharmaceuticals GmbH. Signed by Judge Leonard P. Stark on 4/15/2008. (rpg) |
Filing 64 Joint STIPULATION Regarding Jurisdictional Discovery Schedule by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 4/10/2008. (Court Reporter K. Maurer.) (ntl) |
Filing 63 Letter to Hon. Leonard P. Stark from Jack B. Blumenfeld regarding reply. (Blumenfeld, Jack) |
Filing 62 Letter to The Honorable Leonard P. Stark from Richard L. Horwitz regarding response re discovery dispute - re #61 Letter. (Attachments: #1 Exhibit A)(Horwitz, Richard) |
Filing 61 Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding Forest and Merz's submission prior to telephone conference scheduled for April 10, 2008 at 3:30 p.m.. (Attachments: #1 Exhibit A)(Blumenfeld, Jack) |
Filing 60 Letter to The Honorable Leonard P. Stark from Richard L. Horwitz regarding discovery dispute. (Horwitz, Richard) |
Filing 59 Order Setting Teleconference: Telephone Conference re: Discovery Dispute set for 4/10/2008 03:30 PM before Judge Leonard P. Stark. Please see Order for further details. Signed by Judge Leonard P. Stark on 4/3/2008. (rpg) |
SO ORDERED, re #58 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Terrence J. Connolly, Darryl H. Steensma and Amy Noss of Latham & Watkins LLP filed by Orchid Chemicals & Pharmaceuticals Ltd., Orchid Pharmaceuticals Inc. Ordered by Chief Judge Gregory M. Sleet on 4/1/2008. (asw) |
Filing 58 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Terrence J. Connolly, Darryl H. Steensma and Amy Noss of Latham & Watkins LLP - filed by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. Motions referred to Leonard P. Stark.(Moore, David) |
Filing 57 ANSWER to #49 Answer to Complaint, Counterclaim PLAINTIFFS' REPLY TO DEFENDANTS WOCKHARDT USA INC.'S AND WOCKHARDT LIMITED'S COUNTERCLAIMS by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 56 ANSWER to #47 Answer to Complaint, Counterclaim,, PLAINTIFFS' REPLY TO DEFEDANT COBALT LABORATORIES INC.'S COUNTERCLAIMS by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Blumenfeld, Jack) |
Filing 55 ORDER REFERRING CASE to Magistrate Judge Leonard P. Stark. Signed by Judge Gregory M. Sleet on 3/19/08. Motions referred to Judge Leonard P. Stark.(mmm) |
SO ORDERED, re #54 STIPULATION TO EXTEND TIME - STIPULATION AND ORDER TO EXTEND TIME FOR PLAINTIFFS TO RESPOND TO ORCHID HEALTHCARE'S MOTION TO DISMISS to until either (i) 10 days following the completion of jurisdictional discovery or (ii) 90 days from the date th STIPULATION TO EXTEND TIME - STIPULATION AND ORDER TO EXTEND TIME FOR PLAINTIFFS TO RESPOND TO ORCHID HEALTHCARE'S MOTION TO DISMISS to until either (i) 10 days following the completion of jurisdictional discovery or (ii) 90 days from the date th filed by Merz Pharma GmbH & Co. KGaA, Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Ordered by Chief Judge Gregory M. Sleet on 3/20/2008. (asw) |
Filing 54 STIPULATION TO EXTEND TIME - STIPULATION AND ORDER TO EXTEND TIME FOR PLAINTIFFS TO RESPOND TO ORCHID HEALTHCARE'S MOTION TO DISMISS to until either (i) 10 days following the completion of jurisdictional discovery or (ii) 90 days from the date this Order is signed - filed by Orchid Chemicals & Pharmaceuticals Ltd., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Blumenfeld, Jack) |
Filing 53 REDACTED VERSION of #46 Affidavit of Satish Srinivasan re 44 Opening Brief in Support, re 43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] by Orchid Chemicals & Pharmaceuticals Ltd.. (Attachments: #1 Exhibit A-B)(Horwitz, Richard) |
Filing 52 Disclosure Statement pursuant to Rule 7.1 filed by Orchid Pharmaceuticals Inc. identifying Corporate Parent Orchid Chemicals & Pharmaceuticals Ltd. for Orchid Pharmaceuticals Inc... (Moore, David) |
Filing 51 Disclosure Statement pursuant to Rule 7.1 filed by Orchid Chemicals & Pharmaceuticals Ltd. identifying Corporate Parent None for Orchid Chemicals & Pharmaceuticals Ltd... (Moore, David) |
Filing 50 Disclosure Statement pursuant to Rule 7.1 filed by Wockhardt USA Inc., Wockhardt Limited identifying Corporate Parent Wockhardt EU Operations (Swiss) AG for.. (Farnan, Kelly) |
Filing 49 ANSWER to #1 Complaint,,, COUNTERCLAIM Answer, Affirmative Defenses and Counterclaims of Defendants Wockhardt USA Inc. and Wockhardt Limited against all plaintiffs by Wockhardt USA Inc., Wockhardt Limited.(Farnan, Kelly) |
Filing 48 Disclosure Statement pursuant to Rule 7.1 filed by Cobalt Laboratories Inc.. (Matterer, Mary) |
Filing 47 ANSWER to #1 Complaint,, with Jury Demand Answer, Affirmative Defenses, Counterclaims, and Jury Demand of Defendant Cobalt Laboratories, Inc., COUNTERCLAIM against Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH by Cobalt Laboratories Inc..(Matterer, Mary) |
Filing 46 SEALED AFFIDAVIT of Satish Srinivasan re #44 Opening Brief in Support, re 43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Pharmaceuticals Inc.. (Horwitz, Richard) |
Filing 45 AFFIDAVIT of Dr. C. Bhaktavatsala Rao re #44 Opening Brief in Support, re 43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Chemicals & Pharmaceuticals Ltd.. (Horwitz, Richard) |
Filing 44 OPENING BRIEF in Support re #43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] filed by Orchid Chemicals & Pharmaceuticals Ltd..Answering Brief/Response due date per Local Rules is 3/20/2008. (Horwitz, Richard) |
Filing 43 MOTION to Dismiss for Lack of Jurisdiction Over the Person [FOR LACK OF PERSONAL JURISDICTION] - filed by Orchid Chemicals & Pharmaceuticals Ltd.. (Attachments: #1 Text of Proposed Order)(Horwitz, Richard) |
Filing 42 ANSWER to #1 Complaint,, by Orchid Pharmaceuticals Inc..(Horwitz, Richard) |
Filing 41 MOTION for Pro Hac Vice Appearance of Attorney Douglas C. Hochstetler, D. Christopher Ohly, Sailesh K. Patel, and Luke T. Shannon, of Schiff Hardin LLP - filed by Lupin Pharmaceuticals Inc.. (Attachments: #1 Certificate of Service)(Kirk, Richard) |
SO ORDERED, re #41 MOTION for Pro Hac Vice Appearance of Attorney Douglas C. Hochstetler, D. Christopher Ohly, Sailesh K. Patel, and Luke T. Shannon, of Schiff Hardin LLP filed by Lupin Pharmaceuticals Inc. Ordered by Chief Judge Gregory M. Sleet on 2/27/2008. (asw) |
Filing 40 ANSWER to #35 Answer to Complaint, Counterclaim,, Plaintiffs' Reply to Defendants Lupin Pharmaceuticals, Inc.'s and Lupin Ltd.'s Counterclaims by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Parrett, James) |
Filing 39 MOTION for Pro Hac Vice Appearance of Attorney Peter L. Giunta - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certification of Peter L. Giunta#2 Certificate of Service)(Whalen, Thomas) |
Filing 38 MOTION for Pro Hac Vice Appearance of Attorney Steven J. Lee - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certification of Steven J. Lee#2 Certificate of Service)(Whalen, Thomas) |
Filing 37 MOTION for Pro Hac Vice Appearance of Attorney Merri C. Moken - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certification of Merri C. Moken#2 Certificate of Service)(Whalen, Thomas) |
Filing 36 MOTION for Pro Hac Vice Appearance of Attorney Shelia Mortazavi - filed by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certification of Shelia Mortazavi#2 Certificate of Service)(Whalen, Thomas) |
SO ORDERED, re #36 MOTION for Pro Hac Vice Appearance of Attorney Shelia Mortazavi filed by Teva Pharmaceuticals USA Inc., #38 MOTION for Pro Hac Vice Appearance of Attorney Steven J. Lee filed by Teva Pharmaceuticals USA Inc., #37 MOTION for Pro Hac Vice Appearance of Attorney Merri C. Moken filed by Teva Pharmaceuticals USA Inc., #39 MOTION for Pro Hac Vice Appearance of Attorney Peter L. Giunta filed by Teva Pharmaceuticals USA Inc. Signed by Judge Gregory M. Sleet on 2/15/08. (mmm) |
Filing 35 ANSWER to Complaint, COUNTERCLAIM /ANSWER AND COUNTERCLAIMS OF DEFENDANTS LUPIN PHARMACEUTICALS, INC. AND LUPIN, LTD. against Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH by Lupin Pharmaceuticals Inc., Lupin Ltd..(Kirk, Richard) |
Filing 34 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Orchid Chemicals & Pharmaceuticals Ltd. served on 2/1/2008, answer due 3/3/2008. (Noreika, Maryellen) |
Filing 33 ANSWER to Complaint by Upsher-Smith Laboratories Inc..(Gaza, Anne) |
Filing 32 STATEMENT / Defendant Teva Pharmaceuticals USA, Inc.'s Rule 7.1 Corporate Disclosure Statement by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certificate of Service)(Grey, Joseph) |
SO ORDERED, re #31 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to March 3, 2008 filed by Orchid Chemicals & Pharmaceuticals Ltd., Orchid Pharmaceuticals Inc. Reset Answer Deadlines: Orchid Pharmaceuticals Inc. answer due 3/3/2008; Orchid Chemicals & Pharmaceuticals Ltd. answer due 3/3/2008. Ordered by Chief Judge Gregory M. Sleet on 2/1/2008. (asw) |
Filing 31 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to March 3, 2008 - filed by Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd.. (Horwitz, Richard) |
Filing 30 ANSWER to Complaint by Teva Pharmaceuticals USA Inc.. (Attachments: #1 Certificate of Service)(Grey, Joseph) |
Filing 29 MOTION for Pro Hac Vice Appearance of Attorney David E. Marder, Jake M. Holdreith and Yixin H. Tang - filed by Upsher-Smith Laboratories Inc.. (Cottrell, Frederick) |
SO ORDERED, re #29 MOTION for Pro Hac Vice Appearance of Attorney David E. Marder, Jake M. Holdreith and Yixin H. Tang filed by Upsher-Smith Laboratories Inc. Ordered by Chief Judge Gregory M. Sleet on 1/31/2008. (asw) |
Filing 28 DECLARATION OF MAILING (as to defendant Lupin Pharmaceuticals, Inc.) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A-B)(Noreika, Maryellen) |
Filing 27 DECLARATION OF MAILING (as to defendant Lupin Ltd.) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A-B)(Noreika, Maryellen) |
Filing 26 DECLARATION OF MAILING (as to defendant Upsher-Smith Laboratories, Inc.) by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A-B)(Noreika, Maryellen) |
Filing 25 Disclosure Statement pursuant to Rule 7.1 filed by Upsher-Smith Laboratories Inc. identifying no corporate parent as Corporate Parent. (Gaza, Anne) |
Filing 24 NOTICE of Appearance by Anne Shea Gaza on behalf of Upsher-Smith Laboratories Inc. (Gaza, Anne) |
SO ORDERED, re #23 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Attorney Paul J. Molino, Attorney Deanne M. Mazzochi, Attorney Neil A. Benchell and Attorney John Polivick filed by Cobalt Laboratories Inc. Ordered by Judge Gregory M. Sleet on 1/25/2008. (asw) |
Filing 23 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Attorney Paul J. Molino, Attorney Deanne M. Mazzochi, Attorney Neil A. Benchell and Attorney John Polivick - filed by Cobalt Laboratories Inc.. (Matterer, Mary) |
Filing 22 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Wockhardt Limited served on 1/22/2008, answer due 3/3/2008. (Noreika, Maryellen) |
Filing 21 STIPULATION TO EXTEND TIME for Defendant Cobalt to respond to the complaint to March 3, 2008 - filed by Cobalt Laboratories Inc., Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Matterer, Mary) |
SO ORDERED, re #19 MOTION for Pro Hac Vice Appearance of Attorney F. Dominic Cerrito, Daniel L. Malone and Eric C. Stops filed by Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Ordered by Judge Gregory M. Sleet on 1/23/2008. (asw) |
SO ORDERED, re #21 STIPULATION TO EXTEND TIME for Defendant Cobalt to respond to the complaint to March 3, 2008 filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH, Cobalt Laboratories Inc. Set/Reset Answer Deadlines: Cobalt Laboratories Inc. answer due 3/3/2008. Ordered by Chief Judge Gregory M. Sleet on 1/23/2008. (asw) |
Filing 20 NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Upsher-Smith Laboratories Inc. (Cottrell, Frederick) |
Filing 19 MOTION for Pro Hac Vice Appearance of Attorney F. Dominic Cerrito, Daniel L. Malone and Eric C. Stops - filed by Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) |
SO ORDERED, re #18 STIPULATION TO EXTEND TIME to answer complaint to March 3, 2008 filed by Wockhardt Limited, Wockhardt USA Inc. Reset Answer Deadlines: Wockhardt USA Inc. answer due 3/3/2008; Wockhardt Limited answer due 3/3/2008. Ordered by Judge Gregory M. Sleet on 1/22/2008. (asw) |
Filing 18 STIPULATION TO EXTEND TIME to answer complaint to March 3, 2008 - filed by Wockhardt USA Inc., Wockhardt Limited. (Farnan, Kelly) |
Filing 17 MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Gerald J. Flattmann, Jr. and Melanie R. Rupert - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Noreika, Maryellen) Additional attachment(s) added on 1/17/2008 (asw, ). |
CORRECTING ENTRY: The pdf document in D.I. 17, Motion for Pro Hac Vice has been replaced with its corrected version. (asw) |
SO ORDERED, re #17 MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Gerald J. Flattmann, Jr. and Melanie R. Rupert filed by Merz Pharma GmbH & Co. KGaA, Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Merz Pharmaceuticals GmbH. Ordered by Judge Gregory M. Sleet on 1/17/2008. (asw) |
Case assigned to Judge Gregory M. Sleet and referred to Magistrate-Judge Leonard P. Stark. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
Filing 16 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Wockhardt Limited served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 15 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Orchid Chemicals & Pharmaceuticals Ltd. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 14 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Upsher-Smith Laboratories Inc. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 13 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Lupin Ltd. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 12 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Lupin Pharmaceuticals Inc. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 11 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Orchid Pharmaceuticals Inc. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 10 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Wockhardt USA Inc. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 9 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Teva Pharmaceuticals USA Inc. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 8 SUMMONS Returned Executed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. Cobalt Laboratories Inc. served on 1/11/2008, answer due 1/31/2008. (Noreika, Maryellen) |
Filing 7 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,061,703; US 5,061,703; (lid) |
Filing 6 Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (lid) |
Filing 5 Disclosure Statement pursuant to Rule 7.1 filed by Forest Laboratories Inc.. (lid) |
Filing 4 Disclosure Statement pursuant to Rule 7.1 filed by Forest Laboratories Holdings Ltd. identifying Forest Laboratories Inc. as Corporate Parent. (lid) |
Filing 3 Disclosure Statement pursuant to Rule 7.1 filed by Merz Pharma GmbH & Co. KGaA identifying Merz Pharma GmbH & Co. KGaA as Corporate Parent. (lid) |
Filing 2 Disclosure Statement pursuant to Rule 7.1 filed by Merz Pharmaceuticals GmbH identifying Merz Pharma GmbH & Co. KGaA as Corporate Parent. (lid) |
Filing 1 COMPLAINT filed against Cobalt Laboratories Inc., Lupin Pharmaceuticals Inc., Lupin Ltd., Orchid Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA Inc., Upsher-Smith Laboratories Inc., Wockhardt USA Inc., Wockhardt Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 150251.) - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibits A-B#2 Civil Cover Sheet #3 Acknowledgement of Consent Form)(lid) |
Summons Issued as to Cobalt Laboratories Inc. on 1/10/2008; Lupin Pharmaceuticals Inc. on 1/10/2008; Lupin Ltd. on 1/10/2008; Orchid Pharmaceuticals Inc. on 1/10/2008; Orchid Chemicals & Pharmaceuticals Ltd. on 1/10/2008; Teva Pharmaceuticals USA Inc. on 1/10/2008; Upsher-Smith Laboratories Inc. on 1/10/2008; Wockhardt USA Inc. on 1/10/2008; Wockhardt Limited on 1/10/2008. (lid) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.